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ABSTRACT OF DISSERTATION 
 
 
THE PSYCHOLOGICAL IMPACTS OF FALSE POSITIVE OVARIAN CANCER 
SCREENING: ASSESSMENT VIA MIXED AND TRAJECTORY MODELING 
 
Ovarian cancer (OC) is the fifth most common cancer among women and has the 
highest mortality of any cancer of the female reproductive system. The majority (61%) of 
OC cases are diagnosed at a distant stage. Because diagnoses occur most commonly at a 
late-stage and prognosis for advanced disease is poor, research focusing on the 
development of effective OC screening methods to facilitate early detection in high-risk, 
asymptomatic women is fundamental in reducing OC-specific mortality. Presently, there 
is no screening modality proven efficacious in reducing OC-mortality. However, 
transvaginal ultrasonography (TVS) has shown value in early detection of OC. 
 TVS presents with the possibility of false positive results which occur when a 
women receives an abnormal TVS screening test result that is deemed benign following 
repeat testing (about 7% of the time). The purpose of this dissertation was to evaluate the 
impact of false positive TVS screening test results on a variety of psychological and 
behavioral outcomes using mixed and trajectory statistical modeling. The three specific 
aims of this dissertation were to 1) compare psychological and behavioral outcomes 
between women receiving normal and false positive results, 2) identify characteristics of 
women receiving false positive results associated with increased OC-specific distress and 
3) characterize distress trajectories following receipt of false positive results.  
 Analyses included a subset of women participating in an experimental study 
conducted through the University of Kentucky Ovarian Cancer Screening Program. 750 
women completed longitudinal assessments: 375 false positive and 375 normal results. 
Mixed and group-based trajectory modeling were used to evaluate the specific aims. 
 Results suggest women receiving false positive TVS result experience increased 
OC-specific distress compared to women receiving normal results. Among those 
 
 
receiving false positives, less education, no history of an abnormal screening test result, 
less optimism and more social constraint were associated with increased OC-specific 
distress. Family history was associated with increased distress among women with 
monitoring informational coping styles. Three distinct trajectories characterize the 
trajectory of distress over a four-month study period. Although decreasing over time, a 
notable proportion of women experience sustained high levels of OC-specific distress. 
 
KEYWORDS: false positive, ovarian cancer screening, cancer-specific distress, mixed 
modeling, group-based trajectory modeling 
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1 Introduction 
Ovarian cancer (OC) is the fifth most common cancer among women and has the highest 
mortality of any cancer of the female reproductive system [1].In the United States, the 
age-adjusted incidence rate for OC from 2005-2009 was 12.7 per 100,000 women, while 
the age-adjusted mortality rate was 8.2 per 100,000 women [2]. In 2012, it is estimated 
that 22,280 incident cases will be diagnosed in the US, accounting for nearly 3% of all 
cancers among women. An estimated 15,500 deaths from OC are expected to be reported 
in 2012 in the United States alone. OC represents the fourth leading cause of death for 
women aged 40-59, and the 5
th
 leading cause of death for women aged 60-79 [3]. From 
2005-2009, the median age at diagnosis for OC was 63 years of age, with the highest 
percentage of diagnoses occurring in women between 55 and 64 years of age (23%). 
 The stage at OC diagnoses distribution is disproportionately late-stage with 15% of cases 
diagnosed in localized, 16% in regional and 61% distant [3]. When diagnosed at a 
localized stage, 5-year relative survival is very high (92%), with rates dropping 
considerably for diagnoses in regional and distant stages (72% and 27%, respectively) 
[4]. Because diagnoses occur most commonly at a late stage, and prognosis for advanced 
disease is poor, research focusing on the development of effective ovarian cancer 
screening methods to facilitate early detection in high-risk, asymptomatic women is 
fundamental to decreasing mortality from ovarian cancer.  
Presently, there is no screening modality proven effective to reduce OC-specific 
mortality. Methods have been proposed for early detection consisting of any combination 
of pelvic examination, transvaginal ultrasound (TVS) and blood tests for cancer antigen 
2 
 
125 (CA125). Currently, only four screening trials have been conducted to test the 
efficacy of different screening methods, two of which have been completed with the other 
two ongoing. In these trials,  combinations of screening modalities (pelvic examination, 
CA125 testing and TVS) were considered [5]. As of now, only results from the Prostate, 
Lung, Colorectal and Ovary (PLCO) trial have been reported and showed equivalent rates 
of OC-specific mortality among women receiving screening and those in the usual care 
group [6]. In the other three trials, presentation of results is pending. While the efficacy 
of these methods in reducing OC-specific mortality has not been proven in prospective, 
randomized trials, CA125 assay and TVS have been tested alone and in combination, and 
have shown value in early detection of OC [7-9]. Further, investigators have found TVS 
to be significantly more accurate in defining the dimensions of the ovaries compared to 
clinical pelvic examination alone [10].   
Although early detection through OC screening is critical to improving prognosis of OC, 
it does not come without limitations. Similar to other cancer screening modalities, OC 
screening modalities, such as TVS, present with the possibility of false positive test 
results. Research has shown receipt of a false positive screening test result in any cancer 
screening setting to be associated with affective, cognitive and behavioral outcomes [11, 
12].  
False positive screening test results occur when patients receive an abnormal test result, 
which after repeat screening or further follow-up procedures, confirms no disease exists. 
Researchers have found that false positive mammograms were associated with 
significantly more symptoms of distress, anxiety and worry about future screening and 
breast cancer, illness and death [13]. Additionally, false positive results were associated 
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with generally more breast cancer-specific thoughts such as greater distress, anxiety, 
worry, and more perceived risk of receiving positive results for breast cancer in the future 
[13]. From the University of Kentucky OC screening program, Andrykowski et al. found 
that after receipt of a false positive TVS screening test, women reported elevated OC-
specific stress, but distress returned near baseline levels at four month follow-up [11]. 
Investigators found receipt of an abnormal, yet ultimately benign TVS test to be 
associated with responses to cancer-specific distress rather than generic measures of 
distress, and suggested using cancer-specific distress measures in future studies. 
Recent studies suggest the trajectory of response to an abnormal cancer screening test 
result is associated with how an individual processes information after the occurrence of 
health-threatening events. In order to better characterize the impact of an abnormal TVS 
screening test result, it is important to identify factors that moderate the impact. Two 
conceptual frameworks are used to help understand the trajectory of response to abnormal 
cancer screening results: Monitoring Process (MP) model and the Cognitive-Social 
Health Information Processing (C-SHIP) model [14, 15]. The MP model suggests that 
individuals differ in coping styles for dealing with health-threatening events. The theory 
characterizes individuals' informational coping styles as monitoring (attending to) or 
blunting (avoiding). Termed “monitors”, these individual seek health-related information 
while “blunters” tend to minimize or avoid health-relevant information. Consistent with 
the MP model, Wardle et al. found that monitors experienced greater distress after receipt 
of an abnormal TVS result [16]. 
C-SHIP model theory follows from the MP model but additionally suggests that 
dispositional or situational characteristics can modify monitors’ tendency to amplify 
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threat. Consistent with the C-SHIP model, Andrykowski et al. found that the combination 
of a monitoring informational coping style with low optimism was associated with 
elevated OC-specific stress after receipt of an abnormal TVS screening result, whereas 
high dispositional optimism combined with a monitoring style restrained the response 
[11, 17]. Further, the MP and C-SHIP models predict that family history of OC is 
associated with an increased risk for an adverse response due to an increased perception 
of cancer risk posed by a false positive TVS result. Through specific aims (2) and (3) of 
this dissertation, we will evaluate the association between potential predictors suggested 
by these models and the magnitude and trajectory of OC-specific distress. 
The purpose of this dissertation is to investigate affective, cognitive and behavioral 
responses of women after receipt of an abnormal, yet ultimately benign, TVS screening 
test result for OC. The specific aims of this study are: 
1. Compare affective, cognitive and behavioral outcomes between women 
receiving false positive TVS screening test results and women receiving routine, 
normal screening test results. 
2. Identify a comprehensive set of demographic, clinical, dispositional and social 
environmental characteristics that moderate the magnitude of OC-specific distress 
after receipt of a false positive TVS screening test result for OC. 
3. Use group-based trajectory modeling to characterize trajectories of response to 
a false positive cancer screening test result for OC, and identify characteristics 
associated with likelihood of group membership. 
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We hypothesize that an abnormal, yet ultimately benign, TVS test result will be 
associated with increased OC-specific distress, increased perceptions of personal OC risk, 
reduced perceptions about the efficacy of TVS screening for OC and curability of OC and 
reduced intentions to participate in future TVS screening for OC. For positive affective 
outcomes, we predict that an abnormal TVS result will result in less reassurance and 
well-being but greater “benefit-finding”. Further, we hypothesize that a monitoring 
informational coping style combined with low dispositional optimism or a family history 
of OC will be associated with greater immediate OC-specific distress, and more sustained 
OC-specific stress over the study period. 
While previous research has addressed some of these research questions, this study 
allows for the largest, most comprehensive study of response to a false positive cancer 
screening test result in the OC setting. Because of the large numbers of women receiving 
abnormal results, we have sufficient power to detect more subtle and complex interaction 
effects to test the associations proposed by the MP and C-SHIP models. Although OC 
cancer screening is not currently recommended by any professional organization, the 
availability of study subjects through the University of Kentucky OC screening program 
provides a “natural laboratory” for examining affective, cognitive and behavioral 
responses to a potentially health-threatening event. Of most importance, study findings 
have implications translatable to understanding clinical management of response to false 
positive screening test results for other types of cancers.  
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2 Consequences of False Positive Cancer Screening Test Results for Ovarian 
Cancer: A Literature Review 
Among cancers of the female reproductive system, the disease etiology of OC is least 
well understood. As the fourth or fifth leading cause of cancer death among women in the 
United States, OC causes upwards of 140,000 deaths among women worldwide [18]. 
While the etiology is well established among other cancers of the female reproductive 
system (cervical, endometrial), little is known about causes of this highly fatal disease. 
Descriptive epidemiology of ovarian cancer 
The highest age-adjusted rates of OC are present in developed parts of the world such as 
North America, Northern Europe and Western Europe [19]. The disease occurs more 
commonly among Whites (14.3 per 100,000), with slightly lower rates among African-
Americans (10.1 per 100,000). Over time, incidence rates of OC in North America and 
Europe have remained fairly constant with a slight decline since the 1990s. A slight 
decline in OC-related mortality for all races combined has been seen in the United States 
over time, likely due to advances in treatment methods. Geographical and racial variation 
in OC incidence is likely due to differences in oral contraceptive use and pregnancy, as 
these factors are associated with decreased risk for developing OC. 
OC is typically viewed as an asymptomatic disease as symptoms associated with OC 
have low specificity and low positive predictive value. Common symptoms include 
persistent bloating, abdominal pain, feeling full quickly or frequent or urgent urination 
patterns [2]. The most common symptom is abdominal enlargement, caused by the 
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accumulation of fluid. Although these symptoms are common among women without 
OC, it is recommended to seek medical attention if persistent symptoms occur.  
The cause of OC is not known. The risk for developing ovarian cancer has been 
associated with factors relating to family history, hormones, menstrual history, 
pregnancy, oral contraceptive use and lifestyle factors [19]. Factors associated with 
reduced OC risk are pregnancy, lactation and long-term oral contraceptive use. While 
parity is associated with a decreased OC risk in the general population, a study by 
Vachon et al. found family history of OC in first degree relatives (FDR) to have a 
mediating effect on OC risk [20]. Among women with history of OC in FDR, nulliparous 
women were at significantly higher risk [RR=2.7; 95% CI= (1.1-6.6)] for OC compared 
to parous women, while among women without family history of OC in FDR, the effect 
of parity was marginal. Further, results from a population-based study suggested having 
ever breastfed was associated with a 22% reduction in OC risk among parous women 
[21]. Oral contraceptive use is one the most significant protective risk factors for OC, 
with estimated protection ranging from 30-40% for ever oral contraceptive users, and 
almost a 50% risk reduction in women using oral contraceptives for at least ten years 
[22]. The most well-established risk factor for OC is family history, with a threefold to 
sevenfold increased risk among women with history of disease in FDR [19]. Women who 
take estrogen replacements for 5 years or more are at increased risk for developing OC 
[23]. Inherited germline mutations in BRAC1 or BRAC2 are associated with increased 
lifetime risk of OC. With the lifetime risk of OC for the general population in the United 
States being 1.2%, the estimated lifetime risk of OC significantly raises for women with 
the BRAC1 and BRAC2 mutations (39%-60% and 12%-20%, respectively) [24]. 
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Analogous to many other cancer types, the risk of OC increases with increased age [1].  
Because no definitive symptoms are present with OC, it is estimated that for only 15% of 
patients is the disease confined to the ovary [25].  
Surgery is the primary treatment for OC. Surgery may involve anything from a total 
hysterectomy, bilateral salpingo-oophorectomy, partial or complete removal of the 
omentum or biopsy of the lymph nodes and other tissues in the pelvis and abdomen [1]. 
Chemotherapy is typically used after surgery to treat remaining disease. Over time 5-year 
relative survival rates after an OC diagnoses have increased significantly, likely due to 
improvements in treatment methods. More specifically, survival rates have climbed from 
36% in 1975-1977 to 44% in 2001-2007 for all stages at diagnoses [3]. 
Overview of cancer screening 
Early detection is a fundamental process in the cancer control continuum. For all types of 
cancer, early detection of disease is associated with improved prognosis. The primary 
purpose of cancer screening is to detect cancer before symptoms present, because by the 
time symptoms occur it is likely that the disease may have grown or spread, making it 
harder to treat. For localized cancer, treatment is more effective and sometimes cancer is 
curable. Cancer screening modalities may include physical exams, laboratory tests, 
imaging procedures or genetic testing for genetic predispositions to specific cancers. 
According to the National Cancer Institute, in any cancer screening program there are 
many factors that must be considered when evaluating its necessity [26]. One, the disease 
should be a serious health problem, with the disease having high incidence rates and 
posing substantial threats on morbidity and mortality. Two, the target population to be 
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screened should be clearly defined, with sufficient disease prevalence to justify screening 
costs. Three, the level of expected participation should be sufficient enough to produce 
results that can be meaningfully analyzed. And most importantly, the screening test must 
have acceptable performance characteristics such as sensitivity and specificity.  
Performance characteristics in cancer screening 
Performance characteristics pertain to the diagnostic accuracy of the testing procedure.  
Test performance is often summarized using three quantitative measures: sensitivity, 
specificity and predictive value. Sensitivity is a measure representing the accuracy of a 
testing procedure to adequately identify the presence of disease, while specificity refers 
to the precision of a test to correctly identify non-diseased individuals. These measures 
are a function of possible outcomes of screening: true positives, true negatives, false 
positives and false negatives. The true positive rate is also called sensitivity, and one 
minus the true negative rate is termed specificity. A graphical representation of these 
rates is called a receiver operating curve (ROC), and is frequently presented. It is ideal 
for a cancer screening diagnostic test to have a very low false-positive rate, minimizing 
the number of individuals required to return for further diagnostic or surgical follow-up. 
Figure 2.1 is an example of a hypothetic ROC curve adapted illustrated by Baker, with 
sensitivity along the y-axis and 1-specificity along the x-axis [27]. True positives defined 
as individuals who have the disease of interest and are identified positive by the screening 
test, are the only people who can benefit from screening. Positive predictive value is the 
proportion of individuals with positive screening tests who actually have the disease, and 
is a function of sensitivity, specificity and disease prevalence. In any cancer screening 
modality, high measures of test performance are desired, but the possibility of diagnostic 
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errors (false negative, false positives) always exists. In addition to diagnostic errors, 
cancer screening programs also present with concerns about costs and potential risks of 
harm.  
Ovarian cancer screening trials 
Because no distinct symptoms are present with OC, the overwhelming majority of OC 
cases are diagnosed at a distant stage when prognosis is poor. Therefore, recent studies 
have focused on the development of OC screening methods to aid in early detection of 
the disease. As of today, four prospective trials have been conducted to test the efficacy 
of screening modalities in reducing OC-related mortality. Of the four trials, two have 
been completed and two are ongoing and study locations vary geographically: two have 
been conducted in the United States, one in Japan and one in the United Kingdom. 
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial was a large, 
multicenter, randomized controlled trial conducted in the United States aimed to evaluate 
the efficacy of transvaginal ultrasound and serum cancer antigen 125 (CA125) as 
screening tools to reduce OC-specific mortality [6]. The trial was conducted from 1993-
2001 with follow-up for 13 years from randomization. Women were randomized to either 
the intervention group or usual care group, with the intervention consisting of annual 
TVS and serum CA125 levels measured through blood testing. Eligible participants were 
women who were 55-74 years of age who: had no previous diagnosis of lung, colorectal 
or ovarian cancer, had not previously undergone oophorectomy surgery and were not 
currently using tamoxifen. Women in the intervention group were offered TVS and 
CA125 blood testing at baseline, with an annual TVS for an additional three years and an 
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annual CA125 for an additional five years. The primary outcome of interest in this study 
was mortality from OC, with secondary outcomes of interest including OC incidence and 
complications associated with screening and diagnostic procedures. Results from this trial 
did not show that combination screening reduced OC-related mortality. Almost 10% of 
women in the intervention group experienced a false positive screening test result, and 
15% of them experienced at least one serious complication after surgical follow-up. The 
primary conclusions from this study were that simultaneous TVS and CA125 screening 
compared with usual care does not reduce OC mortality, and follow-up procedures after 
receipt of a false positive screening test results were associated with complications. 
The only other OC screening trial in the United States is being conducted at the 
University of Kentucky [28]. This population-controlled (one-arm) trial began in 1986 
and offers annual TVS screening to asymptomatic, postmenopausal women aged 50 years 
or older as well as premenopausal women 25 years of age or older with a documented 
family history of OC in at least one FDR. This trial has up to 27 years of follow-up and 
remains ongoing. Preliminary results suggest TVS is useful in detecting early stage OC 
(70.2% stage I and II, compared with 27% in general population comparison group). 
Because OC is a very rare disease, an enormous amount of women must be screened to 
detect a small number of cases. According to 2013 trial results, 47 true positives have 
been detected out of over 200,000 women screened. Data from this trial indicate almost 
7% of women with abnormal TVS results present with no evidence of OC after surgical 
follow-up (false positives) [28]. 
 Hirosaki University Ovarian Cancer Screening Program offers annual TVS screening for 
asymptomatic women [7]. The randomized, controlled trial offered TVS screening along 
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with CA125 testing to women at least 30 years of age who presented for cervical 
cytologic screening. Preliminary results from this trial indicate early detection of OC 
(stage I and II) in 82% of women with the disease. Over 40,000 women were screened for 
this trial and 27 true positive OC cases were detected.  
The final OC screening trial is the United Kingdom Collaborative Trial of Ovarian 
Cancer Screening (UKCTOCS) [29]. This randomized, controlled trial accrued 
participants from 2001-2005 and included post-menopausal women aged 50-74. The 
intervention arms received annual TVS screening alone or annual TVS screening 
combined with CA125 testing. Results from the trial indicated 50% stage I and II OC 
cases, with high rates of sensitivity and specificity in both multimodal and TVS alone 
intervention groups. Evidence offered promising characteristics of the proposed screening 
modalities and results are pending for additional follow-up to evaluate the efficacy of 
screening in reducing OC-specific mortality.  
Although results from these trials indicate that OC screening modalities have the ability 
to detect early stage disease, annual screening for OC is not recommended by any 
professional society. Although TVS and CA125 prove effective in the early detection of 
OC with high sensitivity, false positive test results occur and can cause adverse 
psychological and behavioral outcomes as well as complications resulting from invasive 
follow-up and diagnostic procedures. Of interest in this dissertation are the affective, 
cognitive and behavioral outcomes associated with receipt of an abnormal, yet ultimately 
benign, OC screening test result. 
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Outcomes associated with receipt of a false positive cancer screening test 
Abundant literature exists that demonstrates the impact of an abnormal, yet ultimately 
benign, cancer screening test result, with the overwhelming majority focusing on breast 
and cervical cancer screening. Current research suggests that receipt of a false positive 
cancer screening test during annual, routine screening has a significant impact on 
psychological and behavioral outcomes.  
Affective outcomes 
Extensive research focusing on affective endpoints such as general anxiety, depression 
and overall well-being suggests that receipt of an abnormal screening test result is 
associated with increased adverse outcomes within this domain. Researchers have found 
that women receiving false positive cancer screening test results experience significantly 
more distress [30-33], report lower quality of life [34] and suffer from higher levels of 
anxiety [30].  
Cancer-specific psychological morbidities have also been studied, and results suggested 
that women receiving false positive cancer screening results suffered from greater cancer-
specific anxiety, distress and worry [12, 35, 36]. More specifically, a study by Anderson 
et al. found that women with abnormal test results were more than twice as likely to 
report increased levels of cancer worry over a two year screening interval compared to 
women receiving all normal breast cancer screening results [37]. In a meta-analysis of the 
effect of false positive mammograms on psychosocial outcomes, results suggested that 
effects were associated with cancer-specific indices rather than general affective indices 
of psychological morbidities (i.e. distress, anxiety, worry) [38]. 
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Although considerable literature demonstrates the association between an abnormal 
cancer screening test result and adverse affective outcomes, little research has been 
devoted to positive affective outcomes associated with participating in cancer screening 
programs. There is growing literature that investigates the positive ways in which 
individuals’ lives change as a result of a traumatic event, and it has been suggested that 
types of “post-traumatic growth” and benefit-finding are related to improved physical and 
psychological outcomes [39, 40]. A 2006 review of literature examining positive 
consequences after a traumatic life event found for health-threatening stressors, benefit-
finding was associated with decreased depression, global distress and subjective physical 
health, and increased positive well-being. Results from this study indicated that time 
since trauma (both health-threatening and personal traumas) was the most significant 
moderator in the effect sizes for depression, anxiety, positive well-being and global 
distress. Although researchers have examined benefit-finding after the occurrence of 
various stressors (i.e. diagnoses of primary cancers, chronic diseases) [41, 42], little work 
has been done in the context of cancer screening.  
In a study of psychological outcomes of familial ovarian cancer screening, Brain et al. 
found no long term differences in reassurance between women who received a normal 
result and women receiving false positive test results [43]. However, Gaugler et al. found 
that receipt of a normal OC screening test result was associated with positive affective 
outcomes over a four month study period [44]. With conflicting study results, the impact 
of cancer screening test results on positive affective outcomes is not yet well 
characterized. 
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Cognitive outcomes 
Few studies have been conducted that focus on the impact of an abnormal, yet ultimately 
benign, cancer screening result on cognitive outcomes such as personal and comparative 
perceptions of cancer risk and attitudes and beliefs about the efficacy of cancer screening. 
A study by Lipkus et al. found that receipt of a false positive mammogram was associated 
with increased perceptions of lifetime personal breast cancer risk [45]. In a more recent 
study, researchers at the University of Kentucky examined the effect of a false positive 
screening result for OC on perceived personal OC risk as well as comparative risk, 
defined as a woman's lifetime perceived risk for OC compared to a typical woman’s risk 
for OC [46]. Results from this study suggested that women in the false positive group 
reported greater perceived personal risk for OC than women in the regular screened 
group. While women in both groups reported their perceived OC risk to be less than a 
typical woman’s OC risk, the magnitude of comparative risk was significantly smaller in 
the false positive screening group. In a meta-analysis investigating perceived breast 
cancer risk and the relation between perceived risk and breast cancer screening, 
researchers found that women who were asked about their perceived lifetime breast 
cancer risk by way of a numerical question tended to overestimate their risk, while those 
asked in a verbal question tended to present their risk more optimistically [47]. Further, 
the investigators suggested that women held an optimistic bias in the verbal scale but 
significantly overestimated their risk in the numerical scale, suggesting that the two 
measures should be combined to represent a composite measure of risk perception.   
Results pertaining to general attitudes and beliefs about cancer screening programs in 
various cancer settings have been reported. In a population-based study of United States 
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residents, researchers found that most adults (87%) believe routine cancer screening is 
“almost always a good idea”, and the majority believe that early detection saves lives 
“most” or “all of the time” [48]. Specific to OC screening, baseline analysis from the 
UKCTOCS showed that almost all women (99%) believed committed participation in OC 
screening would reduce mortality and 96% of participants believed that cancers detected 
early would have improved prognosis [49]. Although the general population seems to 
agree that early detection through cancer screening is useful in detecting early cancer and 
subsequently improving survival, little is known about how these beliefs are affected by a 
false positive cancer screening test result. 
Schwartz et al. examined women’s attitudes about false-positive mammograms, and 
results indicated that a majority of women (62%) did not take the possibility of false-
positive screening results into account when deciding about screening.  While perceptions 
of personal and comparative lifetime cancer risk and worry about cancer after an 
abnormal cancer screening test result have been reported, very limited research has been 
done to examine how attitudes and beliefs about cancer screening are affected after 
receipt of a false positive test result. Lipkus et al. conducted a study to assess attitudes 
towards mammography screening in women who had history of an abnormal 
mammogram and those who did not [45]. Investigators hypothesized that women with an 
abnormal mammogram within the past 2 years would have more positive attitudes 
towards mammography screening than women who had regular mammograms. Results 
from this study suggested a marginally significant trend (p=0.09) that women who had a 
recent abnormal mammogram reported more positive attitudes towards mammograms 
than women who had not had an abnormal result. However, no such differences were 
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found when comparing women with abnormal mammograms more than two years ago to 
those with normal results. In the breast cancer screening literature, it has been suggested 
that women are aware of the possibility of false-positive screening results, but the 
possibility does not affect their attitudes and beliefs about the efficacy of mammography 
testing. Rather, receipt of a false-positive screening test may heighten their beliefs in the 
efficacy of the screening modality in early detection. While studies have suggested such 
cognitive effects of an abnormal cancer screening test, further research is needed to better 
characterize the impact, especially in the OC screening context. 
Behavioral outcomes  
Although literature exists examining the association between receipt of an abnormal 
cancer screening test result and future participation in cancer screening programs, most 
studies focus on the cervical and breast cancer screening setting. Lipkus et al. conducted 
a cross-sectional study to investigate whether previous history of an abnormal 
mammogram affected screening outcomes [45]. Results from this study indicated that 
women with previous history of abnormal mammograms (within the past 2 years) were 
more likely to have had a clinical breast examination over the past two years, and more 
likely to adhere to mammography screening recommendations, compared to women who 
had never had an abnormal test result. Similarly, in a study of adherence to 
mammography screening, Burman et al. found that women who received a false-positive 
mammography were 20% more likely to return to their next recommended 
mammography screening, compared to women with true-negative index screening test 
results [50]. A meta-analysis of studies conducted in the United States found conflicting 
results that women who received false positive results during routine breast cancer 
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screening were slightly more likely to return to routine screening than women who 
received normal results [RR=1.07; 95% CI=(1.02-1.12)], although no statistically 
significant differences were found among studies of European women [13]. However, for 
the meta-analysis including two studies of Canadian women, receipt of a false-positive 
mammography was associated with a decrease in the likelihood of returning to routine 
screening [RR=0.63; 95% CI=(0.50-0.80)]. With conflicting results, further research 
examining the impact of a false positive screening test result is necessary to better 
distinguish the impact on return for screening. 
Differing theories have been proposed to explain women’s participation in future cancer 
screening programs after receipt of a false positive screening test. In the context of breast 
cancer screening, one may suggest that receiving an abnormal, yet ultimately benign, 
mammogram may discourage women from participating in routine screening, due to 
testing errors weakening women’s beliefs in the efficacy of mammography in early 
detection [51]. Another theory suggests that false-positive cancer screening results may 
not have an effect on return for routine screening. In a study aimed to determine the 
public’s enthusiasm for cancer screening, 98% of subjects were glad they had 
participated in the initial cancer screening even though 29% of individuals characterized 
the experience of receiving false positive results as “very scary”[48]. In this same study, 
among women who have had a false positive mammography test result, 73% reported 
that they are still having mammography tests the same as before.  A third, less commonly 
argued theory is that false positive may be associated with increased participation in 
future screening, due to increases in anxiety, worry and/or perceived risk experienced 
after the event [52]. Whatever the reason may be, understanding behavioral outcomes 
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following false positive cancer screening results is fundamental in understanding the 
impact of a significant health-threatening event.   
Per the theory of planned behavior, it is reasonable to assume that stated intentions are 
positively correlated with behaviors, and stated intentions to participate is useful as a 
surrogate in investigating the effect of an abnormal cancer screening test result on return 
for routine, recommended cancer screening [53]. To our knowledge, no previous study 
has been conducted to examine this relationship in the context of OC screening. 
Throughout the literature it has been well established that abnormal cancer screening tests 
are associated with adverse affective outcomes. While general distress and cancer-
specific distress have been addressed, cognitive outcomes such as attitudes and beliefs 
about cancer screening, or behavioral outcomes pertaining to intentions to participate in 
future cancer screening programs have not yet been explored in the OC screening 
context. Although researchers have examined general (and cancer-specific) indices of 
affective outcomes, the impact of an abnormal cancer screening test result on positive 
affective outcomes, such as benefit-finding and reassurance, is not yet well characterized. 
Further, factors associated with the trajectory of psychological response over time remain 
unknown.  
Factors associated with the magnitude and trajectory of psychological response over 
time 
It is reasonable to assume the magnitude and trajectory of psychological response to a 
health-threatening event is determined in part by an individual’s situational factors and 
dispositional characteristics. The monitoring process (MP) model was developed to 
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analyze how informational styles relate to coping when dealing with potentially life-
threatening events. Termed “high monitors”, these individuals scan for information 
pertaining to the event, and tend to translate neutral or ambiguous information as 
threatening, leading to exaggerated perceptions of personal risk [54]. While low 
monitors, or “blunters”, tend to avoid threat-relevant information. In a study by Wardle et 
al., researchers found evidence supporting the MP model that women with an 
information-seeking coping style (i.e. monitors) were more adversely affected by 
abnormal screening results for OC than women with blunting coping styles (i.e. blunters) 
[16]. In a study of women participating in an annual TVS screening program for OC, 
results supported the impact of informational coping style on OC-specific distress after an 
abnormal screening test result [17]. Findings suggested that a combination of a 
monitoring coping style and low optimism was associated with elevated OC-specific 
distress after an abnormal TVS screening result. The authors proposed that the impact of 
a monitoring coping style was restrained when high optimism was also present in the 
context of an abnormal screening test result as a health-threatening event. Because 
informational coping styles have been shown to be associated with psychological 
responses to health-threatening events, identification and treatment of individuals at high-
risk, who are more likely to experience distress, may lead to improved quality of life and 
may help promote early detection of cancer [54]. 
 More recently, Andrykowski et al. conducted a study to test the Cognitive-Social Health 
Information Processing (C-SHIP) model [14] theory that proposes dispositional or 
situational characteristics combined with coping style may moderate the trajectory of 
OC-specific distress triggered by an abnormal TVS screening test result [17]. In this 
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study, researchers found a high monitoring coping style combined with family history of 
OC was associated with increased OC-specific distress after a false positive screen. 
Consistent with findings from a previous study of cancer-specific distress after breast 
biopsy, family history of disease seemed to induce additional distress already experienced 
among monitoring women [12]. It has been well established that receiving false positive 
cancer screening test results is associated with increased, short-term cancer-specific 
distress [13, 55]. Although, little research has examined factors associated with the 
magnitude and trajectory of cancer-specific distress over time.  
Steffens et al. conducted a study to determine the demographic and clinical factors 
associated with the magnitude of distress during the benign breast biopsy (BBB) 
experience after abnormal mammography results [56]. In this study, researchers found 
lower age, less education and no family history of breast cancer to be significantly 
associated with greater distress. Contradicting these results, a study on the impact of BBB 
found number of first degree relatives with breast cancer to be significantly associated 
with greater avoidance scores (as a measure of OC-specific distress) [12]. Further, this 
study evaluated dispositional factors associated with magnitude of distress. Results 
showed that among women in the BBB group, a monitoring informational coping style 
was most strongly associated with distress when optimism was low, supporting theories 
proposed by the MP model.  
Through specific aims (2) and (3) of this dissertation, we examine the features – out of a 
comprehensive set of demographic, clinical, dispositional and situational factors – that 
are associated with high-risk profiles for OC-specific distress. As these demographic, 
clinical and situational factors are easily identifiable, they provide a simple, cost-effective 
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means of stratifying risk for distress in the OC screening setting. Further, categorization 
of dispositional characteristics allows identification of women who are more likely to 
suffer from increased distress. It is clinically relevant to identify these factors to provide 
interventional programs to moderate OC-specific distress after the occurrence of a 
potentially health-threatening event. 
Several studies have demonstrated that a high monitoring information coping style is 
associated with not only elevated levels of distress, but more persistent distress in 
response to threatening events [16, 57, 58]. In a study by Andrykowski et al. examining 
the psychological impact of benign breast biopsy, researchers found a decrease in breast 
cancer-specific distress over time, with significant differences between baseline and 4-
month follow-up assessments [12]. Although previous studies have identified decreases 
in adverse psychological responses over time in women participating in cancer screening 
trials, to our knowledge, no study has examined factors associated with the trajectory of 
cancer-specific distress within the false positive group alone. By modeling intraindividual 
OC-specific distress trajectories, we will be able to identify factors associated with 
changes over time. Further, we will be able to identify which women are at high risk for 
experiencing long-term adverse psychological distress to better characterize which 
individuals need treatment to moderate their response to a potentially health-threatening 
event. 
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Figure 2.1 Example receiver operator curve 
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3 Affective, Cognitive and Behavioral Outcomes Associated with a False Positive 
Screening Test Result for Ovarian Cancer 
Introduction 
Ovarian cancer (OC) is the fifth most common cancer among women and has the highest 
mortality of any cancer of the female reproductive system [1]. In 2012, an estimated 
22,280 incident cases were, accounting for nearly 3% of all cancers among women and 
approximately 15,500 deaths were reported in the United States. OC represents the fourth 
leading cause of death for women aged 40-59, and the fifth leading cause of death for 
women aged 60-79 [3].  
 The distribution of stage at OC diagnosis is disproportionately late-stage with 15% of 
cases diagnosed with localized disease, 16% with regional and 61% with distant disease 
[3]. When diagnosed at a localized stage, 5-year relative survival is very high (92%), with 
rates dropping considerably for diagnoses in regional and distant stages (72% and 27%, 
respectively) [4]. Because diagnoses occur most commonly at a late stage, and prognosis 
for advanced disease is poor, research focusing on the development of effective OC 
screening methods to facilitate early detection in high-risk, asymptomatic women is 
fundamental to decreasing mortality from ovarian cancer. Presently, there is no screening 
method proven effective in reducing OC-specific mortality. Methods have been proposed 
for early detection of OC including pelvic examination, transvaginal ultrasonography 
(TVS) and blood tests for cancer antigen 125 (CA125), alone or in combination. While 
the efficacy of these methods in reducing OC-specific mortality has not been proven in 
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prospective, randomized trials, the CA125 assay and TVS have been tested alone and in 
combination, and have shown value in early detection of OC [7-9].  
Although early detection through OC screening is critical to improving prognosis of OC, 
it does not come without limitations. Similar to other cancer screening modalities, TVS 
screening for OC presents with the possibility of false positive screening test results. 
False positive screening test results occur when patients receive an abnormal screening 
test result, after which repeat screening or further follow-up procedures confirms no 
disease exists. Research has shown receipt of a false positive screening test result in any 
cancer screening setting can impact a variety of affective, cognitive and behavioral 
outcomes [11, 12]. 
 Affective outcomes 
Extensive research focusing on affective endpoints such as general anxiety, depression 
and overall well-being suggests a false positive screening test result is associated with 
increased adverse outcomes. Researchers have found that women receiving false positive 
cancer screening test results experience significantly more distress [30-33], report lower 
quality of life [34] and suffer from higher levels of anxiety [30]. Cancer-specific 
psychological morbidities have also been studied, suggesting that women receiving false 
positive cancer screening results report greater cancer-specific anxiety, distress and worry 
[12, 35, 36]. In the OC screening setting, researchers found women receiving false 
positive TVS screening test results for OC reported elevated short-term OC-specific 
stress. Distress declined over time, but remained elevated at four month follow-up [11]. 
Additionally, investigators found that receipt of an abnormal, yet ultimately benign, TVS 
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test result was associated with increased cancer-specific distress rather than generic 
measures of distress, and suggested using cancer-specific distress measures in future 
studies [13]. 
Although considerable literature demonstrates the association between a false positive 
screening test result and adverse affective outcomes, little research has been devoted to 
examining potential positive affective outcomes associated with participating in cancer 
screening programs or false positive screening test results. There is a growing literature 
that investigates the positive ways in which individuals’ lives change as a result of a 
traumatic event, and it has been suggested that benefit-finding is related to improved 
physical and psychological outcomes [39, 40]. A 2006 review of literature examining 
positive consequences after a traumatic life event found for health-threatening stressors, 
benefit-finding was associated with decreased depression, global distress and subjective 
physical health, and increased positive well-being[39]. Although researchers have 
examined benefit finding after the occurrence of various stressors (i.e. diagnoses of 
primary cancers, chronic diseases, etc. [41, 42]), little work has been done in the context 
of cancer screening. In a study of psychological outcomes of familial ovarian cancer 
screening, Brain et al. found no long term differences in perceived positive consequences 
of cancer screening between women receiving normal results and women receiving false 
positive test results [43]. However, a study by Gaugler et al. found receipt of a normal 
OC screening test result to be associated with positive affect over a four month study 
period [44]. These studies focused on different target populations, with conflicting study 
results; the impact of cancer screening test results on positive affective outcomes remains 
unclear. 
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Cognitive outcomes 
Few studies have been conducted on the impact of a false positive screening test result on 
cognitive outcomes such as perceptions of lifetime cancer risk and attitudes and beliefs 
about the efficacy of cancer screening. A study by Lipkus et al. found that receipt of a 
false positive mammogram was associated with increased perceptions of lifetime 
personal breast cancer risk [45]. In a more recent study, researchers at the University of 
Kentucky examined the effect of a false positive screening test result for OC on perceived 
personal OC risk as well as comparative OC risk, defined as perceived personal lifetime 
risk for OC compared to perceptions of a typical woman’s risk for OC [46]. Results 
suggested women receiving false positive results report greater perceived personal risk 
for OC than women receiving normal screening test results. While women in both groups 
reported their perceived OC risk to be less than what they perceived to be a typical 
woman’s OC risk, the magnitude of comparative risk was significantly smaller in the 
false positive screening group. 
Results pertaining to general attitudes and beliefs about cancer screening procedures in 
various cancer settings have been reported. In a population-based study of U.S. residents, 
researchers found most adults (87%) believe routine cancer screening is “almost always a 
good idea”, and the majority of adults believe early detection saves lives “most” or “all of 
the time” [48]. Specific to OC screening, baseline analysis from the University of 
Kentucky Ovarian Cancer Screening Program showed almost all women (99%) believed 
committed participation in OC screening would reduce mortality and 96% of participants 
believed cancers detected early would have improved prognosis [49]. Although the 
general population seems to agree early detection through cancer screening is useful in 
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detecting early cancer and subsequently improving survival, little is known about how 
these beliefs are affected by a false positive cancer screening test result.  
Behavioral outcomes 
Literature examining the association between receipt of a false positive screening test 
result and future participation in cancer screening programs has focused on cervical and 
breast cancer screening. Lipkus et al. conducted a cross-sectional study to investigate 
whether a previous history of a false positive mammogram affected subsequent screening 
behavior [45]. Results indicated women with a previous history of abnormal, yet 
ultimately benign, mammograms (within the past 2 years) were more likely to have had a 
clinical breast examination over the past two years, and more likely to adhere to 
mammography screening recommendations, compared to women who had never had an 
abnormal mammogram result. Similarly, in a study of adherence to mammography 
screening, Burman et al. found women who received a false positive mammogram were 
20% more likely to return to their next recommended mammography screening, 
compared to women with normal mammogram results [50]. A meta-analysis of studies 
conducted in the United States concluded women who received false positive results 
during routine breast cancer screening were slightly more likely to return for routine 
screening than women who received normal results. In contrast, no statistically 
significant differences were found among studies of European women [13]. However, for 
the meta-analysis including two studies of Canadian women, receipt of a false positive 
mammogram was associated with a decrease in the likelihood of returning for routine 
screening. With conflicting results, further research examining the impact of a false 
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positive screening test result is necessary to determine the impact of a false positive test 
on return for screening. 
The present study characterizes the impact of a false positive screening test result during 
routine participation in a TVS screening program for OC. More specifically, we 
examined differences in affective, cognitive and behavioral outcomes in women 
receiving false positive screening test results and those receiving normal results during 
routine screening. We hypothesized that an abnormal, yet ultimately benign, TVS test 
result would be associated with increased OC-specific distress, less positive 
consequences of screening but greater benefit-finding, increased perceptions of personal 
OC risk, reduced perceptions about the efficacy of cancer screening and reduced 
intentions to participate in future cancer screening programs in general. 
Methods 
Sample 
Participants represent a subset of individuals participating in a broader, quasi-
experimental study evaluating affective, cognitive and behavioral outcomes associated 
with receipt of an abnormal, yet ultimately benign, TVS screening test result identified 
during routine screening through the University of Kentucky Ovarian Cancer Screening 
Program (UKOCSP). Ethical approval for this study was obtained from the University of 
Kentucky Institutional Review Board. 
The UKOCSP offers free, annual screening to asymptomatic women at least 50 years of 
age and asymptomatic women 25-50 years of age with at least one first degree relative 
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with OC. Women receiving an abnormal TVS screening test result during the course of 
routine, annual screening are asked to return within 2-12 weeks for a repeat TVS test. 
Eligibility for participation in this study of psychosocial and behavioral response to TVS 
screening was dependent upon study group definition.  Eligible women were identified 
from UKOCSP records. Women who received an abnormal TVS screening test result 
within the past 12 weeks, and were scheduled to return for additional follow-up were 
identified. Upon arrival at the clinic at the time of their scheduled follow-up appointment, 
these women met with research staff and consented to participate in the study. These 
women comprised the abnormal screening (AS) group. To be included in the routine 
screening (RS) study group, a woman must have matched with a woman already enrolled 
in the AS study group based on the following criteria: 1) age (+/- 5 years), 2) number of 
prior routine screening tests received on the program (+/- 1 test), and 3) history of prior 
abnormal TVS test result (yes vs. no). Women in the RS study group were identified 
through clinic records and were enrolled at the clinic prior to receipt of their annual, 
routine TVS screening test. All participants were enrolled in the study from 2004 to 2009. 
Procedure 
A baseline interview was completed following study enrollment immediately prior to the 
participant's scheduled repeat or routine TVS screening test. Women in the RS study 
group received a normal TVS screening test result and completed two follow-up 
telephone interviews, one month and four months following their baseline interview. 
Women in the AS study group completed their baseline assessment prior to their 
scheduled repeat TVS screening test. Women in the AS study group also completed two 
follow-up telephone interviews, one month and four months after their baseline 
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assessment. All women in the AS study group were notified prior to the one month 
follow-up interview that results of their repeat TVS screening test were benign. Less than 
5% of eligible women invited to participate declined participation. Figure 3.1 provides a 
graphical depiction of participant flow and longitudinal administration of assessments.  
Measures 
All participants completed questionnaires assessing demographic and clinical 
information, dispositional information, mental and physical functioning, distress, benefit-
finding, positive consequences of screening, perceived OC risk, beliefs about cancer 
screening, and intentions to participate in future cancer screening programs. 
Demographic, clinical and dispositional information were assessed only at baseline, 
whereas all other measures were completed at all baseline and follow-up assessments by 
both study groups. Only the AS group was assessed for benefit-finding and positive 
consequences of screening at the baseline assessment. 
Demographic and clinical information 
Demographic information assessed by self-report included age, race/ethnicity, partner 
status, education, income and clinical information relevant to OC risk including personal 
history of breast cancer and family history of OC. Family history of OC (yes vs. no) was 
determined based on whether or not the woman had a first-degree relative (FDR) with 
OC (mother, sister or daughter). Clinical information collected from clinic records 
included number of previous TVS screening tests and prior lifetime history of abnormal 
TVS screening test result (yes versus no).  
Dispositional characteristics 
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Dispositional optimism was assessed using the Life Orientation Test-Revised (LOT-R) 
[59]. The LOT-R is a standardized, commonly used 10-item measure of dispositional 
optimism and yields a total optimism score. Informational coping style was measured 
using the Miller Behavioral Styles Scale-Short Form (MBSS-SF) [60]. The MBSS-SF 
consists of 2 stressor scenarios followed by 8 statements representing different coping 
strategies for that stressor. Separate Monitoring and Blunting scores were computed, only 
the Monitoring score was used in subsequent analyses.  
Mental and Physical Functioning 
Mental and physical functioning were assessed using the Medical Outcomes Study 12-
Item Short Form Health Survey (SF-12) [61]. The SF-12 is a standardized, commonly 
used measure of physical and mental health status in both medical and healthy examples. 
Only the physical and mental health subscale scores were used in subsequent analyses. 
Outcome measures 
Distress 
General distress was assessed by the Centers for Epidemiologic Studies Depression Scale 
(CESD) [62]. The CESD is a 20-item measure of current depressive symptoms and yields 
a total depression symptom score. As such, it is a measure of general distress. 
OC-specific distress was assessed by the Impact of Events Scale (IES) [63]. The IES is a 
standardized, commonly used 15-item measure of current distress associated with a 
specific stressor. Women completed the IES with regard to “the possibility that you will 
develop ovarian cancer in your lifetime." The IES yields subscale scores for Intrusion and 
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Avoidance. The Intrusion subscale consists of 7 items which measure intrusive symptoms 
(intrusive thoughts, nightmares, unpleasant feelings and imagery). The Avoidance 
subscale consists of 8 items which measure avoidance symptoms (numbing of 
responsiveness, avoidance of feelings, situations and ideas). Respondents are asked to 
rate the frequency of each item occurring within the past 7 days according to the scale: 
(0) not at all, (1) rarely, (3) sometimes and (5) often. Responses are summed over each 
subscale, with the following possible range of responses: Intrusion (0-35) and Avoidance 
(0-40). A copy of the IES instrument is available in the Appendix. 
Positive consequences of screening 
Benefits were assessed using the Benefit-Finding Questionnaire (BFQ) [64]. The BFQ is 
a 17-item instrument assessing benefits derived following a specific event, in this case – 
“my most recent experience with the University of Kentucky Ovarian Cancer Screen 
Program.” The BFQ yields a total benefit-finding score. 
Positive consequences of cancer screening were assessed using the Psychological 
Consequences Questionnaire (PCQ) [65]. The PCQ is a standardized 22-item measure of 
positive (i.e. reassurance) and negative consequences of breast cancer screening. While 
developed for use in the breast cancer screening setting, the authors indicate the PCQ can 
be modified for use in other screening settings. Only the 10-item positive consequences 
subscale was used and the PCQ was modified by changing references from "breast 
cancer" and "breast cancer screening" to "ovarian cancer" and "ovarian cancer 
screening".  
Perceived OC-risk 
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Two estimates of lifetime OC risk were obtained: personal and comparative. Personal 
lifetime risk for OC was assessed based on responses from two questions. First, women 
estimated personal lifetime risk for OC by providing a percentage between 0 and 100 in 
response to the question “What do you think are the chances that you will develop 
ovarian cancer during your lifetime?” [12] Second, women were asked "How likely do 
you think you are to develop ovarian cancer at some point during your life?" with ordinal 
response options ranging from (1) "no chance" to (6) "certain to happen". Responses 
from these two questions were standardized with respect to baseline mean and standard 
deviation and summed to create a composite measure of personal lifetime OC risk. 
Typical lifetime risk for OC was formed using women's personal and typical lifetime 
perceived OC risk estimates. Typical lifetime risk for OC was assessed based on 
responses from two questions. First, women estimated typical lifetime OC risk by 
providing a percentage between 0 and 100 in response to the question "What do you think 
the chances are that the typical woman your age will develop ovarian cancer during her 
lifetime?" [12, 66]. Second, women were asked "Compared to other women your age, do 
you think your chances of getting ovarian cancer during your lifetime are: (1) higher than 
other women my age, (2) about the same as other women my age or (3) lower than other 
women my age?". Responses from these two questions were standardized (to baseline 
mean and standard deviation) and summed to create a composite measure of typical 
lifetime OC risk. 
Finally, a comparative measure of OC risk was calculated by subtracting the typical risk 
measure from the personal risk measure. Thus, a positive comparative OC risk value 
indicated a perception that personal risk of OC was greater than a typical woman's OC 
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risk. The personal and comparative OC risk measurements were used in subsequent 
analyses. 
Cancer screening beliefs  
Participants indicated their extent of agreement with two statements: “A Transvaginal 
Sonography screening test can find ovarian cancer early” and “Ovarian cancer can be 
cured if found early” [66]. Responses were recorded on identical 4-point Likert scales 
ranging from strongly disagree to strongly agree. Responses were summed to create a 
single index of OC screening effectiveness with higher scores reflecting stronger beliefs 
in the effectiveness of OC screening. Similar questions were asked regarding 
mammography for breast cancer and sigmoidoscopy for colorectal cancer, and screening 
effectiveness scores for each were calculated in the same manner. 
Cancer screening intentions 
Intentions for participation in future OC screening were assessed with the following 
question: “How likely is it that you will return for another TVS screening test for ovarian 
cancer by       ?” Here, research staff filled in the blank with the appropriate date for next 
recommended screening (i.e. one year from last screening date), with ordinal response 
options ranging from (1) "I definitely will" to (5) "I definitely will not". The same 
questions were asked regarding intentions to participate in mammography screening. 
Statistical analyses 
Data were summarized descriptively, including means and standard deviations for 
continuous variables and frequency distributions for categorical variables. Bivariate 
36 
 
analyses to evaluate the unadjusted associations between demographic/clinical 
characteristics and study group were performed using linear mixed models (LMM) and 
generalized linear mixed models (GLMM) to account for potential correlations between 
individual matches. Multivariate associations for normally distributed outcomes of 
interest were conducted using a two-group (AS versus RS) LMM repeated measures 
analysis [67]. Two-group (AS versus RS) GLMM repeated measures analysis was used 
for non-normally distributed outcomes. Because a considerable proportion of respondents 
exhibited none of the responses (i.e. a zero response) measured by the CESD or the 
Intrusion and Avoidance subscales of the IES, the Zero-Inflated Poisson (ZIP) 
distribution was the assumed underlying probability distributions for these three models. 
Results of adjusted (G)LMM analyses were reported as estimates of mean differences or 
mean ratios, as appropriate, with accompanying 95% confidence intervals. Multivariate 
models were adjusted for education, mental and physical functioning (SF-12), MBSS-SF 
Monitoring and LOT-R Optimism scores. The effect size calculated was Cohen's d. All 
analyses for this paper were generated using SAS software, Version 9.3 of the SAS 
System for Windows.  
Results  
The study sample consisted of 750 women: 375 in the AS group and 375 in the RS group. 
The demographic and clinical characteristics by study group are shown in Table 3.1. 
Women in AS and RS study groups were very similar with respect to demographic 
characteristics, with the only exception being years of education. Women in the AS group 
were significantly more educated than women in the RS group (Mean (SD)AS=14.0 (2.8) 
versus Mean (SD)RS=13.6 (2.9); p=0.03). Study group participants were similar on the 
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majority of clinical characteristics pertaining to OC, but a significantly higher proportion 
of women in the AS study group reported ever being diagnosed with breast cancer 
(12.5% in AS versus 5.9% in RS; p=0.002). 
Results of the adjusted GLMM and LMM analyses are reported in Table 3.2. Table 
values include estimates of mean ratios (AS vs. RS) or mean differences (AS-RS), 
confidence intervals, appropriate p-values for tests of differences at each time point and 
effect sizes. Mean ratios greater than 1 suggest increased distress responses in the AS 
group compared to the RS group.  
Distress 
There was no significant Group*Time interaction effect for CESD depression scores 
(p=0.57). Women in the AS group expressed somewhat lower depression scores but no 
significant difference was observed between AS and RS women over the four month 
interval post-screening. 
According to the first IES ZIP model there was a significant Group*Time interaction 
effect for IES-Avoidance scores. This interaction, shown in Figure 3.2, suggests women 
in the AS group exhibited higher IES-Avoidance measures at each time point relative to 
the RS group, with observed differences decreasing over time. For baseline and one-
month assessments AS women reported over three times as many estimated mean 
avoidant thoughts as RS women, and still almost two times as many at the four-month 
follow-up. Small to medium effect sizes were observed, ranging from 0.19-0.54 
deviations. A trend toward significance (p=0.06) was observed in the Group*Time 
interaction effect in IES-Intrusion scores. This interaction, shown in Figure 3, resembles 
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the changes in group differences over time in IES-Intrusion scores. Although the overall 
Group*Time interaction effect was not significant at the 0.05 level, AS women reported 
significantly higher mean intrusive thoughts compared to women in the RS group at each 
time point. Again, small to medium effect sizes were observed ranging from 0.22-0.44 
deviations. 
Positive Consequences 
No significant Group*Time interaction effect was observed in benefit-finding.  No 
significant differences were observed at either assessment between AS and RS women 
(see Table 2). 
Although there was no significant Group*Time interaction effect for positive 
consequences of screening (p=0.16), AS women reported significantly lower mean 
positive consequences of screening at each time point compared to RS women (one-
month: MDAS-RS = -1.42, p=0.03; four-month: MDAS-RS = -2.27, p=0.002). Effect sizes 
were in the small to medium range. 
Perceived OC-risk 
Although no significant Group*Time interaction effect was observed for personal or 
comparative lifetime perceived OC-risk, AS women reported significantly higher 
perceived personal and comparative risk at almost every assessment (see Table 2 and 
Figure 4). For personal OC-risk, AS women reported significantly higher perceived 
lifetime OC risk at baseline and one-month assessments with small to moderate effect 
sizes ranging from 0.22-0.23. 
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Lifetime perceived comparative OC-risk differed significantly between groups at each 
time point, with AS women perceiving the magnitude of their comparative (personal-
typical) OC-risk greater than RS women at all assessments with small to moderate effect 
sizes ranging from 0.23-0.31.  Unadjusted mean comparative OC-risk estimates by 
groups over time are displayed in Figure 3.5. 
Cancer Screening Beliefs  
For ovarian cancer, breast cancer and colorectal cancer screening effectiveness, no 
differences in the beliefs of AS and RS women were observed at any time point, nor were 
any significant Group*Time interaction effects observed. 
Cancer Screening Intentions 
As shown in Table 2, there was no significant Group*Time interaction effect observed in 
intentions to participate in future TVS screening for OC. However, women in the AS 
group reported significantly elevated intentions at the one-month assessment (MDAS-RS 
=0.09, p=0.01). Analyses limited to women at least 50 years of age (N=590) indicated no 
significant Group*Time interaction effect, nor significant group differences at any time 
point, in intentions to participate in future mammography screening for breast cancer.  
Discussion 
In general, the study results support the hypotheses that receipt of a false positive TVS 
test result during routine OC screening impacted a variety of affective, cognitive and 
behavioral outcomes. 
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With respect to affective outcomes, receipt of a false positive TVS result had little impact 
on a generic measure of distress (CESD) but had significant impact upon a more cancer-
specific measure of distress (IES). This is consistent with other studies which suggest 
false positive cancer screening test results are associated with increased cancer-specific 
distress [12, 35, 36]. Consistent with findings from Andrykowski et al., our results 
indicate a short-term effect on OC-specific distress that dissipates over time [11], but still 
remains significantly elevated at 4-months relative to the RS group. As suggested by 
previous researchers [11, 38], results from the current study indicate event-specific 
measures of distress to be more appropriate in measuring the impact of a health-
threatening event than generic distress measures. 
The heightened distress after receipt of a false positive TVS result may warrant the 
development and testing of interventions to minimize distress. Cancer-specific distress 
not only decreases overall well-being and quality-of-life, but may also adversely impact 
future cancer-related preventive behavior, such as participation in screening. Future 
research should identify variables associated with greater distress in response to false 
positive TVS test results so that interventions might be appropriately targeted to the most 
vulnerable, at risk women.  
This study also examined the impact of a false positive TVS result on positive affective 
outcomes, including measures of benefit-finding and perceived positive consequences of 
screening. Contrary to our hypothesis, results showed no effect of screening test results 
on benefit-finding. In contrast, as hypothesized, receipt of a normal TVS screening test 
result was associated with reports of increased positive consequences of screening such 
as reassurance and feelings of well-being. This is consistent with findings from previous 
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research suggesting women with normal OC screening test results reported higher 
positive consequences of screening [44].  
Study findings supported our hypotheses related to the impact of false positive TVS 
results on cognitive outcomes. Consistent with findings in the breast cancer screening 
setting [45], our results indicate an increased perception of lifetime OC risk following a 
false positive screening test result, with this effect observed in both measures of personal 
and comparative OC risk. Similar to findings from a previous smaller study [46], we 
observed an increased perception of lifetime OC risk in AS women at each assessment, 
with the largest effects observed in the short-term.  Women in the AS study group 
reported significantly higher perceptions of comparative OC risk at all assessments. 
Again, the most significant impact of receipt of a false positive TVS result on 
comparative OC risk was observed in the short-term. Heightened risk perceptions may 
negatively impact quality of life or motivate avoidant behavior that could result in a 
reduced likelihood of participation in future cancer screening [68, 69]. Conversely, 
increased risk perception may have a positive impact if it motivates participation in risk-
reducing behavior, such as participation in cancer screening programs [47, 70].  
 The effect of false positive screening test results on cognitive outcomes – including 
beliefs about screening efficacy for OC, breast and colorectal cancer have not previously 
been examined in the literature.  While we did not observe any impact of a false positive 
result on screening efficacy beliefs for ovarian, breast or colorectal cancer screening, lack 
of significant findings may have been due to the insensitivity of the measurement used. 
Specifically, we observed a "ceiling effect", as the overwhelming majority of women 
agreed, or strongly agreed, the selected screening methods are effective and the selected 
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cancers can be cured if detected early. This finding indicates that within our study 
population, the belief that cancer screening is highly effective is so well in-grained that a 
false positive screening test result had little effect on women’s beliefs. It would be 
interesting to see if this result is observed in other populations. 
With respect to behavioral outcomes, at best, our results indicate a small, temporary 
increase in intention to participate in future TVS screening in the AS group. Again, lack 
of significant findings may be due to the insensitivity of the one-item measurement used. 
In fact, at least 90% of women reported they "definitely will" return in one year for TVS 
screening when asked at each assessment. While intentions are known to be an important 
precursor to actual behavior [53], further research is needed to identify the impact of false 
positive screening test results on actual OC screening participation. 
Strengths and limitations 
The present study is the largest, most comprehensive study to date focusing on the impact 
of a false positive cancer screening test result on psychosocial and behavioral outcomes. 
While previous research has examined the impact of false positive OC screening test 
results on a variety of outcomes, samples sizes were limited with only 33 women 
included in the AS group [11]. In the present study, relatively large sample sizes in both 
groups permitted the inclusion of potential confounding factors while also examining the 
role of time in the association between receipt of a false positive screening test result and 
outcomes of interest.  Further, the use of advanced statistical techniques allowed for the 
appropriate specification of the underlying probability distribution of the distress 
outcome measures (CESD, IES-Intrusion and IES-Avoidance). Additionally, this study 
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evaluated the association between false positive screening test results and positive 
outcomes (i.e. benefit-finding and positive consequences of screening), which have 
received only limited attention in the cancer screening setting. 
Several limitations to our study should be noted. First, because TVS screening for OC is 
not presently recommended for mass screening of asymptomatic women, it is unknown 
whether our results can be generalized to other cancer screening tests that are broadly 
recommended (i.e. mammography). However, it should be noted that while TVS 
screening for OC is not endorsed for the general population, the women in this study 
generally endorsed very strong beliefs in the value of TVS screening. Second, as noted in 
other publications from studies conducted through the UKOCSP, our sample consisted of 
predominantly Caucasian women. Thus, our findings may not be generalizable to 
racial/ethnic minority women. Although this study's large sample size allowed for the 
examination of complex associations of interest, results with respect to cancer screening 
beliefs and intentions to participate in future screening are likely limited due to the 
relative insensitivity of the measurements used. Therefore, a more thorough examination 
of the impact of false positive cancer screening test results is warranted within these 
domains.   
Conclusions 
Results from this study suggest receipt of a false positive TVS screening test result is 
associated with increased OC-specific distress, less perceived positive consequences of 
screening and increased perceptions of lifetime OC risk. The impact upon future 
screening behavior not yet well-characterized for OC. This study indicates that women’s 
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beliefs in the effectiveness and intentions to participate in future ovarian, breast and 
colorectal cancer screenings were not affected by false positive OC screening test results. 
However, it is unknown whether women’s actual behavior in participating in future 
screening was affected. If women who received a false positive TVS test result were 
found to reduce their participation effective cancer screening such as for breast, 
colorectal or cervical cancer, this would support the argument for not recommending OC 
screening test with low specificity and positive predictive values. 
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Table 3.1 Unadjusted associations among demographic and clinical characteristics 
and study group 
 AS group 
N
a
=375 
N (%) 
RS group 
N
a
=375 
N (%) 
P
 
Demographic 
characteristics 
   
Mean age at study  
   entry (SD) 
56.8 (11.7) 58.0 (10.6) .13 
Race 
   White 
   Non-white 
 
364 (97.1) 
11 (2.9) 
 
367 (97.9) 
8 (2.1) 
.49 
Ethnicity  
   Hispanic 
   Non-Hispanic 
 
4 (1.1) 
371 (98.9) 
 
1 (0.3) 
374 (99.7) 
.21 
Partnered status 
   Partnered 
   Non-partnered 
 
292 (77.9) 
83 (22.1) 
 
278 (74.1) 
97 (25.9) 
.23 
Mean number years  
   of education  
   completed (SD) 
 
14.0 (2.8) 
 
13.6 (2.9) 
.03 
Household income ($) 
   ≤ 20,000 
   20,001 - 40,000 
   40,001 - 80,000 
   > 80,000 
 
52 (14.1) 
97 (26.2) 
131 (35.4) 
90 (24.3) 
 
63 (17.3) 
108 (29.7) 
113 (31.0) 
80 (22.0) 
.10 
Clinical 
characteristics 
   
Mean number of  
   previous TVS tests  
   (SD) 
4.2 (4.98) 
 
4.0 (4.53) .70 
History of abnormal 
TVS test result 
   Yes 
   No 
 
 
78 (20.8) 
297 (79.2) 
 
 
78 (20.8) 
297 (79.2) 
-- 
Family History of OC 
in FDR 
   No 
   Yes  
 
 
211 (64.3) 
117 (35.7) 
 
 
225 (70.1) 
96 (29.9) 
.11 
Ever had BC 
   Yes 
   No 
 
47 (12.5) 
328 (87.5) 
 
22 (5.9) 
353 (94.1) 
.002 
Abbreviations: SD, standard deviation, TVS, transvaginal ultrasonography FDR, first-degree relative, OC, 
ovarian cancer, BC, breast cancer 
a
 Numbers vary due to sporadically missing data 
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Table 3.2 Multivariate associations among study group and outcome measures 
 Baseline 1-month 4-month Group*Time 
effect 
  
Estimated  
MRAS vs. RS 
(95% CI) 
ES
b 
 
Estimated 
MRAS vs. RS 
 (95% CI) 
ES
b
 
 
Estimated 
MRAS vs. RS 
 (95% CI) 
ES
b
  
 
p
a 
 
Distress 
   CESD
c
 
 
 
    
   IES 
   Avoidance 
 
    
   
   Intrusion 
 
 
0.88  
(0.76, 1.02) 
0.13 
 
 
3.67 
(2.72, 4.95)
***
 
0.54 
 
3.08 
(2.31, 4.12)
***
 
0.44 
 
0.92 
(0.79, 1.08) 
0.06 
 
 
3.70  
(2.62, 5.23)
***
 
0.39 
 
3.42 
(2.49, 4.79)
***
 
0.36 
 
0.86  
(0.74,0.99)
* 
0.15 
 
 
1.91 
(1.35, 5.23)
**
 
0.19 
 
2.29 
(1.66, 3.17)
***
 
0.22 
 
.57 
 
 
 
 
.01 
 
 
 
.06 
  
Estimated  
MDAS-RS 
(95% CI) 
ES
b
 
 
Estimated  
MDAS-RS 
 (95% CI) 
ES
b
 
 
Estimated  
MDAS-RS 
 (95% CI) 
ES
b
  
 
 
p
a 
 
Positive 
outcomes 
   Benefit- 
   finding
d 
 
 
 
-- 
 
 
1.67  
(-1.52, 4.86) 
.08 
 
 
-0.29  
(-3.17, 2.85) 
-.01 
 
 
 
.13 
     
   Positive     
   Consequences     
   of screening
d 
 
-- -1.42  
(-2.64, -0.20)
* 
.19 
-2.27  
(-3.46, -1.08)
** 
.31 
.16 
     
Lifetime 
perceived OC risk 
   Personal 
   
    
 
 
0.23  
(0.09, 0.37)
** 
.23 
 
 
0.17 
 (0.03, 0.31)
* 
.22 
 
 
0.12  
(-0.04, 0.26) 
.13 
 
 
.13 
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 Table 3.2 cont.   
   Comparative 
 
0.37  
(0.19, 0.55)
*** 
.31 
 
 
0.31  
(0.13, 0.49)
** 
.23 
 
0.24  
(0.06, 0.42)
** 
.24 
 
.14 
     
Cancer screening 
beliefs 
   OC screening  
   effectiveness 
    
 
   BC screening  
   effectiveness    
 
    
   CRC screening  
   effectiveness 
 
 
-0.02 
(-0.16, 0.13) 
.02 
 
-0.08 
(-0.23, 0.07) 
.09 
 
-0.12 
(-0.27, 0.02) 
.13 
 
 
-0.01 
(-0.16, 0.13) 
.01 
 
-0.01 
(-0.17, 0.14) 
.03 
 
0.08 
(-0.03, 0.20) 
.11 
 
 
-0.02  
(-0.16, 0.12) 
.03 
 
-0.02  
(-0.17, 0.12) 
.03 
 
-0.10  
(-0.25, 0.04) 
.12 
 
 
.99 
 
 
 
.66 
 
 
 
.37 
     
Intentions to 
participate in 
future screening 
   TVS 
    
 
 
   MAM
e 
 
 
 
0.05  
(-0.01, 0.12) 
.12 
 
0.02  
(-0.12, 0.16) 
.02 
 
 
 
0.09  
(0.02, 0.16)
* 
.20 
 
-0.08 
 (-0.22, 0.06) 
.09 
 
 
 
0.001  
(-0.07, 0.07) 
.002 
 
0.05  
(-0.09, 0.19) 
.04 
 
 
 
.15 
 
 
.27 
Abbreviations: CI, confidence interval, ES, effect size, OC, ovarian cancer, TVS, transvaginal 
ultrasonography,  
MAM, mammography, BC, breast cancer, SIG, sigmoidoscopy, CRC, colorectal cancer 
Models adjusted for education, mental and physical functioning, MBSS-SF-Monitoring score and LOT-R 
optimism 
*
p<.05, 
**
p<.01, 
***
p<.001 
a 
p-value from overall group*time interaction fixed effect F test 
b 
Effect size is Cohen's d
 
c
 Model adjusted for education, physical functioning, MBSS-SF-Monitoring score and LOT-R optimism 
d
 Evaluated at 1-month and 4-month assessments only 
e 
Analysis limited to  women at least 50 years of age (n=590)  
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Routine screening (RS) group 
                                                     
                                                                
Abnormal screening (AS) group 
 
Figure 3.1 Participant flow and longitudinal assessment administration 
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screening test 
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follow-up 
assessment 
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follow-up 
assessment 
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Initial TVS 
screening 
 
Abnormal 
TVS 
screening test 
result 
received 
follow-up 
TVS 
screening 
 
baseline 
assessment 
completed 
Normal TVS 
screening test 
result 
received 
1 month 
follow-up 
assessment 
administered 
4 month 
follow-up 
assessment 
administered 
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Figure 3.2 Estimated average IES-Intrusion score +/- 1 SE 
50 
 
 
Figure 3.3 Estimated average IES-Avoidance score +/- 1 SE 
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Figure 3.4 Estimated average standardized personal OC risk +/- 1 SE 
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Figure 3.5 Estimate average standardized comparative OC risk +/- 1 SE 
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4 Demographic, Clinical, Dispositional and Social Environmental Characteristics 
Associated with Cancer-Specific Distress and Perceived Risk Following a False 
Positive Screening Test Results for Ovarian Cancer: A Longitudinal Study 
Introduction 
Although the benefits of early detection and diagnosis are well recognized in a variety of 
cancer settings, it is less well recognized that participation in cancer screening programs 
can have a negative psychological impact, even when a malignancy is not found [12, 13, 
17, 55].  Because the cancer screening setting has the potential for false positive test 
results, it provides a “natural laboratory” for examining psychological response to a 
potentially health threatening event – here, receipt of an abnormal, yet ultimately benign, 
transvaginal sonography (TVS) screening test result for ovarian cancer (OC). This setting 
provides an opportunity to examine theories or models of coping and adaptation of 
psychological responses to stressful or threatening events. It is also of interest to examine 
the demographic and clinical characteristics that moderate the psychological response 
following receipt of a false positive TVS screening test result for OC. Determining the 
factors associated with adverse psychological reactions following false positive test 
results would enable professionals to recognize women who may need additional 
psychological support as they progress through the follow-up procedures after receiving a 
false positive screening test result.   
A model relevant to understanding individual differences in psychological response to an 
abnormal cancer screening test result is the Cognitive Social Health Information 
Processing (C-SHIP) model [15]. The C-SHIP model is a broad conceptual framework 
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for understanding response to potentially health-threatening events. The C-SHIP model is 
an expansion of the Monitoring Process model (MP) [14]. The MP model suggests 
individuals differ in regard to their informational coping style, the extent to which they 
seek health-relevant information, and the manner in which they respond to health-
threatening events. Termed “monitors”, these individuals scan for information pertaining 
to the event, and tend to translate neutral or ambiguous information as threatening, 
leading to exaggerated perceptions of personal risk [54]. In contrast, low monitors, or 
“blunters”, tend to avoid threat-relevant information. The C-SHIP model extends the MP 
model by suggesting the tendency of monitors to amplify threat can be modified by 
dispositional and situational characteristics.  
Wardle et al. found evidence supporting the MP model, suggesting monitors were more 
adversely affected by abnormal screening test results for OC than blunters [16]. 
Consistent with the C-SHIP model, a monitoring informational coping style was most 
strongly associated with distress when optimism was low following a benign breast 
biopsy [12]. Following receipt of a false positive screening test for OC, distress was 
highest in monitors with low dispositional optimism and a family history of OC [11]. 
Similarly, a 2011 study found monitoring to be associated with increased OC-specific 
distress when family history of OC in a first-degree relative (FDR) was present [17]. 
 Although both the MP and C-SHIP models have been examined in the OC setting, 
results of these cross-sectional studies are based on small samples of women receiving 
false positive test results. The present study involves a larger sample (n=375) of women 
receiving false positive OC screening test results, and investigates factors associated with 
distress and risk perception through longitudinal follow-up.  
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Social environmental characteristics (social support and constraint) have also been 
suggested to impact adaptation to stressful events across a variety of health and medical 
settings (i.e. cancer survivorship, cardiovascular disease, chronic disease diagnosis, [71, 
72]). Social support may serve as a buffer in the mental adaptation process after stressful 
life events. Social constraint refers to the direct or indirect efforts of the social 
environment (i.e. family and friends) to limit or punish an individual's attempts to discuss 
thoughts or feelings referring to their trauma-related experience [73]. Social constraint 
has been associated with less desirable psychological outcomes (i.e. greater distress) 
following medically health-threatening events [17, 74]. According to the Social Cognitive 
Process (SCP) model [75], successful adaptation is achieved through adequate cognitive 
and emotional processing of a stressful event, which can be fostered by a social 
environment which is high in social support and low in social constraint. Results from the 
most recent study conducted in the OC screening setting found higher social constraint 
levels were associated with increased OC-specific distress following a false positive TVS 
screening test result [17]. In contrast, results from this study did not indicate a significant 
association between social support and OC-specific distress.   
Demographic and clinical factors may also moderate psychological response following 
receipt of a false positive OC screening test result. The majority of research has been 
conducted within the breast cancer screening setting and includes both women receiving 
false positive mammography results as well as normal (no malignancy suspected) results. 
Steffens et al. conducted a study examining the impact of the benign breast biopsy (BBB) 
experience and found lower age, less education and no family history of breast cancer to 
be significantly associated with greater distress [56]. Conversely, another study of the 
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BBB experience found the number of first-degree relatives (FDR) with breast cancer to 
be significantly associated with greater baseline breast cancer-specific distress [12]. 
In 2008, Brain et al. examined predictors of breast cancer-related distress following 
mammography screening among younger women with a family history of breast cancer 
[76]. Results from this study suggested higher baseline perceived breast cancer risk, 
higher baseline distress, having previously undergone breast cancer screening, having 
been recalled for further tests, and low levels of optimism to be associated with higher 
cancer worry at one-month follow-up. At six months follow-up, baseline worry, higher 
perceived risk, death of a relative from breast cancer within the past year and having 
previously been part of the screening program were significantly associated with breast 
cancer worry. 
The purpose of the present study is to identify factors – out of a comprehensive set of 
demographic, clinical, dispositional and social environmental characteristics – associated 
with increased OC-specific distress and perceptions of OC risk over the four month study 
period. This study is the largest, most comprehensive study of response following a false 
positive screening test result in the OC setting, employing a longitudinal design and 
examination of affective and cognitive responses. Though no previous studies have 
examined perceptions of lifetime cancer risk in this context, it has been reported that 
women receiving false positive TVS screening test results have increased perceptions of 
personal OC risk [46, 77].                 
We hypothesize that lower age, less education, no prior history of abnormal screening 
test results, lower optimism, greater social constraint and a monitoring informational 
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coping style combined with family history of OC in a FDR will be associated with OC-
specific distress.  
Methods 
Sample 
Participants represent a subset of individuals participating in a broader, quasi-
experimental study evaluating affective, cognitive and behavioral outcomes associated 
with receipt of an abnormal, yet ultimately benign, TVS screening test result identified 
during routine screening through the University of Kentucky Ovarian Cancer Screening 
Program (UKOCSP). Ethical approval for this study was obtained from the University of 
Kentucky Institutional Review Board. 
The UKOCSP offers free, annual screening to asymptomatic women at least 50 years of 
age and asymptomatic women 25-50 years of age with at least one first degree relative 
with OC. Women receiving an abnormal TVS screening test result during the course of 
routine, annual screening are typically asked to return within 2-12 weeks for a repeat 
TVS test.  Women who received an abnormal TVS screening test result within the past 12 
weeks, and scheduled to return for additional follow-up were identified from clinic 
records. Upon arrival at the clinic at the time of their scheduled follow-up appointment, 
these women met with research staff and consented to participate in the study. All 
participants were enrolled in the study from 2004-2009.  
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Procedure 
Figure 1 displays a graphical representation of longitudinal assessment administration. A 
baseline interview was conducted by project research staff and was completed following 
study enrollment immediately prior to the participant's scheduled repeat TVS screening 
test. Women completed their baseline assessment prior to their scheduled repeat TVS 
screening test. Following, women also completed two follow-up telephone interviews, 
one month and four months after their baseline assessment. All women were notified 
prior to the one month follow-up interview that results of their repeat TVS screening test 
were benign. Less than 5% of eligible women who were invited to participate declined 
participation.  
Measures 
All participants completed questionnaires assessing demographic and clinical 
information, dispositional characteristics, social environmental characteristics, mental 
and physical functioning, risk perception, and distress. Demographic, clinical, 
dispositional and physical functioning information was assessed only at baseline, whereas 
risk perception, social environmental and distress information was captured at baseline 
and both follow-up assessments. Only baseline measures of social environmental 
variables were used in subsequent analyses. 
Demographic and clinical information 
Demographic information assessed by self-report included age, race/ethnicity, partner 
status, education, income and clinical information relevant to OC risk including personal 
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history of breast cancer and family history of OC. Family history of OC (yes vs. no) was 
determined based on whether or not the woman had a FDR (mother, sister or daughter) 
with OC. Clinical information collected from clinic records included number of previous 
TVS screening tests and history of abnormal TVS screening test result prior to their most 
recent abnormal screening test result (yes versus no). 
Dispositional characteristics 
Dispositional optimism was assessed using the Life Orientation Test-Revised (LOT-R) 
[59]. The LOT-R is a standardized, commonly used 10-item measure of dispositional 
optimism and yields a total optimism score. Informational coping style was measured 
using the Miller Behavioral Style Scale-Short Form (MBSS-SF) [60]. The MBSS-SF 
consists of 2 stressor scenarios followed by 8 statements representing different coping 
strategies for that stressor. Separate Monitoring and Blunting scores were computed; only 
the Monitoring score was used in subsequent analyses.  
Social environmental characteristics 
Social support was assessed using the Duke-UNC Functional Social Support 
Questionnaire (Duke-SSQ) [78]. The Duke-SSQ is a standardized, commonly used, 8-
item measure of functional social support yielding a total functional (i.e. affective) social 
support score. Social constraint was assessed using the 15-item "Friends and Family" 
version of  Social Constraint Scale (SCS) [73]. The SCS is a commonly used measure of 
the extent an individual's social environment inhibits expression of thoughts and feelings 
about a stressful event – in this case, "your experience with ovarian cancer screening". A 
total social constraint score is calculated. 
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Physical Functioning 
Physical functioning was assessed using the Medical Outcomes Study 12-Item Short 
Form Health Survey (SF-12) [61]. The SF-12 is a standardized, commonly used measure 
of physical and mental health status in both medical and healthy examples. The physical 
functioning subscale score was used in subsequent analyses. 
OC risk perception 
Perceptions of absolute lifetime risk for OC were assessed based on responses from two 
questions. First, women estimated personal lifetime risk for OC by providing a numerical 
response (0-100) to the question “What do you think are the chances that you will 
develop ovarian cancer during your lifetime?” [12] Second, women were asked to 
provide a verbal response to the question "How likely do you think you are to develop 
ovarian cancer at some point during your life?" with ordinal response options ranging 
from (1) "no chance" to (6) "certain to happen". Because researchers have suggested 
women tend to overestimate their risk in the numerical scale and underestimate their risk 
in the verbal scale [47], a composite measure of risk was created. Responses from these 
two questions were standardized (with respect to baseline mean and standard deviations) 
and summed to create a composite measure of personal lifetime perceived OC risk.  
OC-Specific distress 
OC-specific distress was assessed by the Impact of Events Scale (IES) [63]. The IES is a 
standardized, commonly used 15-item measure of current distress associated with a 
specific stressor. Women completed the IES with regard to “the possibility that you will 
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develop ovarian cancer in your lifetime." The IES yields subscale scores for Intrusion and 
Avoidance. The Intrusion subscale consists of 7 items which measure intrusive symptoms 
(intrusive thoughts, nightmares, unpleasant feelings and imagery). The Avoidance 
subscale consists of 8 items which measure avoidance symptoms (numbing of 
responsiveness, avoidance of feelings, situations and ideas). Respondents are asked to 
rate the frequency of each item occurring within the past 7 days according to the scale: 
(0) not at all, (1) rarely, (3) sometimes and (5) often. Responses are summed over each 
subscale, with the following possible range of responses: Intrusion (0-35) and Avoidance 
(0-40). A copy of the IES instrument is available in the Appendix. 
Statistical Analyses 
Study sample characteristics were presented descriptively, including frequencies or 
means and standard deviations, as appropriate. Summary statistics of longitudinal 
outcome measures were presented as means and standard deviations for normally 
distributed outcomes, or medians and interquartile ranges for non-normally distributed 
outcomes. A shared random effects generalized linear mixed model was used to identify 
factors associated with the magnitude of OC-specific distress over time. As the two 
subscales scores of the IES were highly correlated, a shared random effect (intercept per 
subject) was assumed to account for the correlation among observations per individual. 
Thus, the intercept was allowed to vary by individual but shared over each outcome. 
Because a notable proportion of participants exhibited none of the items measured by the 
subscales of the IES (i.e. a zero response), the Zero-Inflated Poission (ZIP) distribution 
was the assumed underlying probability distribution in the GLMM.  
62 
 
A linear mixed model was used to identify factors associated with the magnitude of OC 
risk perception at each time point. A random intercept was used to account for 
correlations among observations per individual.  
Both initial models included age, education, family history of OC in a FDR, history of an 
abnormal TVS screening test result, number of prior routine TVS screens, physical 
functioning, monitoring informational coping style, dispositional optimism, social 
support, social constraint and the interaction between monitoring coping style and family 
history of OC in a FDR. However, because the interaction was not significant in the 
personal OC risk model, it was removed for final analyses. For the OC-specific distress 
models, the effect of family history was estimated at different levels (low, medium and 
high) of monitoring informational coping style to better explain the interaction. These 
levels were determined based on the first (25%), second (50%) and third (75%) quartiles 
of the distribution of monitoring. All analyses were conducted using SAS Software, 
Version 9.3 for Windows, with an alpha level of 0.05 throughout (Cary, NC). 
Results 
Analysis included 375 women who received false positive TVS screening test results 
during routine screening through the UKOCSP. The mean age was 56.7 years (SD=11.7) 
and the mean years of education completed was 14.0 years (SD=2.8). The majority of 
women were married or partnered (78%), White (97%), had no history of an abnormal 
TVS screen for OC (79%) and had no history of OC in a FDR (69%) ( Table 4.1).  
Longitudinal descriptive statistics for IES subscale scores and OC risk perception indices 
are displayed in Table 4.2. Participant retention was very good throughout the study, with 
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92% and 88% of women responding at the one- and four-month assessments, 
respectively. General longitudinal patterns were similar between IES subscale scores, 
with ranges narrowing over time. Regardless of IES subscale, the majority of OC-specific 
distress scores decreased over time, as expected. A slight increase in OC risk perception 
was observed at one-month, with a decline at the four-month assessment. 
Tables 4.3 and 4.4 display results from the multivariate models examining factors 
associated with OC-specific distress and OC risk perception, respectively. Cell values in 
Table 4.3 represent estimated mean ratios and can be interpreted as the mean change in 
response corresponding to a one unit-increase for a continuous covariate, adjusting for all 
other factors in the model. For categorical covariates, the estimated mean ratios 
correspond to the estimated mean change in response associated with one level of the 
covariate compared to the other level (i.e. yes versus no).  Estimated mean ratios greater 
than 1 indicate an increase in distress associated with an increase in the factor.  
In general, controlling for all other covariates in the model, less education,  a greater 
number of previous routine TVS screens, no history of an abnormal screening test result, 
less optimism and more social constraint were associated with greater OC-specific 
distress (Table 4.3). Factors associated with greater perceptions of personal OC risk 
included: lower age, less education, less optimism and more social constraint, adjusting 
for all other factors in the model (Table 4.4). 
During the period of uncertainty (from the abnormal TVS test result to the time of the 
baseline assessment) experiencing an abnormal TVS result for the first time, increased 
social constraint and low optimism were associated with increased OC-specific distress. 
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However, once the results of the abnormal TVS test were resolved and concluded to be 
benign, having been through the abnormal result experience no longer affected distress. 
While lower optimism was associated with an increased distress in women even after the 
results of the test were resolved (at one-month), optimism was not associated with 
distress at the four-month assessment. While the previous characteristics were associated 
with a short-term response, lower education and being newer to the UKOCSP appeared to 
have a more intermediate response. Lower education was associated with increased 
distress at both the one- and four-month assessments as measured by both subscales of 
the IES. Fewer previous routine TVS screens was associated with increased distress at the 
four-month assessment (estimated MRint=0.94, 95% CI=(0.89, 0.98); Table 4.3.).  
The effect of monitoring on OC-specific distress was dependent on family history of OC 
in a FDR. When monitoring was low, family history of OC in a FDR did not have much 
of an effect, but when medium to high monitoring was present, family history was 
associated with an increase in both intrusive and avoidant thoughts. The highest effect 
was observed at the four-month follow-up assessment, as women with history of OC in a 
FDR reported over three times the OC-specific distress among high monitors, compared 
to those with no family history of OC in a FDR (estimated MRavd=3.17, 95% CI=(1.92, 
5.21); Table 4.3) . The effect of monitoring was associated with slightly increased 
distress at baseline when family history of OC in a FDR was absent. However, this effect 
was only observed at the baseline assessment.   
While characteristics were associated with affective responses at some time points and 
not others, this was not observed for the cognitive outcome. For perceptions of absolute 
lifetime OC risk, younger age, less education, lower optimism and higher social 
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constraint were associated with an increased risk perception at all three points of 
assessment. Moreover, the effect of family history of OC in a FDR on perceptions of OC 
risk was not dependent on level of monitoring. Regardless of the level of monitoring, 
family history of OC in a FDR was associated with increased perceptions of OC risk at 
all assessments. Monitoring coping style had no effect on OC risk perception, regardless 
of family history status. 
Discussion 
Results supported the majority of our hypotheses regarding OC-specific distress. Based 
on the C-SHIP model, we hypothesized a monitoring informational coping style 
combined with family history of OC in a FDR would be associated with increased OC-
specific distress. As measured by both subscales of the IES, women characterized by 
family history of OC in a FDR and medium or high informational coping styles 
experienced greater OC-specific distress at all assessments. This replicates prior research 
conducted in the breast cancer [12] and OC settings [17]  and demonstrates the C-SHIP 
model’s theory of the presence of dispositional characteristics with situational factors – in 
this case, family history of OC in a FDR, to amplify threat associated with potentially 
health-threatening events. 
Also consistent with our hypotheses, increased OC-specific distress was associated with 
lower dispositional optimism and higher social constraint. Our findings replicate results 
reported from a recent, cross-sectional study examining factors associated with OC-
specific distress following false positive TVS screening test results [17]. This study found 
higher social constraint and lower optimism to be associated with increased OC-specific 
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distress at baseline. Not only does our study replicate findings, but results extend to one- 
and four-month participant follow-up. At the one-month assessment, when results of 
repeat TVS screening are known to be benign, lower optimism remained significantly 
associated with increased distress and by the four-month follow-up, optimism was no 
longer associated with distress. For social constraint, our results replicate baseline 
findings suggested by Andrykowski et al. [17], and further show increased social 
constraint to be significantly associated with increased OC-specific distress through to 
the four-month follow-up.  
Overall, we conclude no prior history of an abnormal TVS screening test result to be the 
most significant demographic or clinical predictor of OC-specific distress immediately 
following receipt of an abnormal result. However, once the test result is known to be 
benign, this association disappears and lower education has the most significant 
intermediate effect on distress, with this effect remaining at the four-month follow-up. 
Months after the results of the abnormal test are known to be false positives, less 
experience with the screening program (fewer previous routine TVS screening tests) is 
associated with increased OC-specific distress. Based on our findings, we can conclude 
that lower education, less experience with the screening program, a social environment 
characterized by high social constraint and family history among high monitors are 
associated with increased OC-specific distress several months after the false positive 
screening test result experience.  
 
While a few studies have examined perceptions of lifetime personal OC-risk following a 
false positive TVS screening test results [77], no previous research has identified 
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demographic, clinical, dispositional or social environmental characteristics associated 
with changes in OC risk perception. Following a false positive TVS screening test result, 
we found younger age, less education, lower optimism, higher social constraint and 
family history of OC in a FDR to be associated with increased perceptions of lifetime 
OC-risk. Because perceptions of risk are elements of contemporary models evaluating 
health behavior, including cancer screening behavior [79], it is critical to identify what 
characteristics are associated with women who experience increased perceptions of 
cancer risk, as increased risk may motivate or hinder participation in cancer screening 
programs which are recommended for mass screening. 
Strengths and limitations 
This study extends earlier research on response to false positive TVS screening test 
results for OC during participation in a routine screening program by including a larger 
number of women with false positive results and including longitudinal assessment of 
distress and risk perception outcomes. Because OC screening is not currently 
recommended for asymptomatic women and a greater proportion of the women who 
chose to participate in the screening were White, married or partnered and more educated 
than the general population, our sample does not represent the general population who 
would participate in a generally recommended cancer screening program.  
Conclusions 
Results from this study replicate findings from a smaller, similar study conducted in 
similar setting [17] as well as provide additional information regarding characteristics of 
women associated with likelihood of experiencing adverse psychological response over 
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time. Based on findings from this study, women with no history of an abnormal screen, 
low dispositional optimism and a social environment characterized by high social 
constraint are at high risk for experiencing increased immediate OC-specific distress 
following receipt of a false positive TVS screening test result for OC. Further, women 
who are newer to the screening program, have lower dispositional optimism or 
constraining social environments experience increased distress at four-month follow-up.  
Additionally, results indicate younger age, less education, lower dispositional optimism, a 
social environment characterized by high social constraint and family history of OC are 
associated with increased OC risk perception at all assessments. Because we can easily 
identify characteristics of individuals associated with adverse psychological and 
cognitive responses following this potentially health-threatening event, interventional 
programs can be targeted to moderate these effects among high risk women. 
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Table 4.1 Characteristics of the study sample 
 Frequency 
 or Mean (SD) 
Demographic  
Age 56.7 (11.7) 
Marital status 
   Married or partnered 
   Single or non-partnered 
 
292  
83 
Years of education completed 14.0 (2.8) 
Race 
   White, Non-hispanic 
   Other 
 
364 
11 
Clinical  
History of abnormal OC screening test 
   Yes 
   No 
 
78 
297 
History of OC in FDR 
   Yes 
   No 
 
117 
258 
Number of previous OC screening tests 
Number of days between abnormal OC screening test and baseline 
assessment 
4.2 (5.0) 
53.4 (27.5) 
Abbreviations: SD, standard deviation, OC, ovarian cancer, FDR, first-degree relative. 
 
 
 
Table 4.2 Longitudinal descriptive statistics for IES subscale scores and OC risk 
perception 
 Baseline 
(N=374) 
1-month 
(N=347) 
4-month 
(N=331) 
IES-Avoidance 
   Median (IQR) 
   Mean (SD) 
   Range 
 
5 (0-13) 
7.85 (8.70) 
0-38 
 
0 (0-5) 
4.41 (7.03) 
0-36 
 
0 (0-3) 
3.40 (6.75) 
0-34 
IES-Intrusion 
   Median (IQR) 
   Mean (SD) 
   Range 
 
3 (0-9) 
5.26 (6.39) 
0-30 
 
0 (0-5) 
3.40 (5.23) 
0-27 
 
0 (0-4) 
2.86 (5.10) 
0-24 
OC Risk Perception 
   Mean (SD) 
 
0.00 (0.92) 
 
0.17 (1.01) 
 
0.15 (0.94) 
Abbreviation: IQR, interquartile range
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Table 4.3 Results from multivariate analysis examining factors associated with OC-
specific distress 
Coefficient OC-Specific Distress 
Estimated Mean Ratio (95% CI) P
a 
Baseline 1-Month 4-Month 
Age
b 
   Avoidance 
   Intrusion
 
 
0.972 (0.834, 1.134) 
1.000 (0.851, 1.175) 
 
1.046 (0.878, 1.246) 
1.023 (0.857, 1.220) 
 
1.159 (0.951, 1.412) 
1.165 (0.958, 1.418) 
 
.239 
.632 
Education 
   Avoidance 
   Intrusion 
 
0.948 (0.895, 1.004) 
0.931 (0.877, 0.987)
* 
 
0.905 (0.849, 0.964)
 †
 
0.921 (0.864, 0.982)
 *
 
 
0.882 (0.817, 0.951)
 †
 
0.909 (0.846, 0.978)
 *
 
 
.003 
.026 
Physical 
Functioning 
   Avoidance 
   Intrusion 
 
 
1.005 (0.999, 1.011) 
1.005 (0.999, 1.010) 
 
 
1.006 (0.999, 1.013) 
1.006 (0.999, 1.013) 
 
 
1.001 (0.994, 1.009) 
0.998 (0.991, 1.006) 
 
 
.150 
.070 
Previous # 
routine TVS 
screens 
   Avoidance 
   Intrusion 
 
 
 
1.001 (0.964, 1.039) 
1.003 (0.966, 1.042) 
 
 
 
0.991 (0.951, 1.034) 
0.973 (0.933, 1.015) 
 
 
 
0.930 (0.882, 0.980)
 †
 
0.936 (0.890, 0.983)
 †
 
 
 
 
.022 
.015 
History of 
abnormal TVS 
screen 
   Avoidance 
   Intrusion 
 
 
 
0.573 (0.340, 0.965)
* 
0.534 (0.332, 0.858)
 †
 
 
 
 
0.634 (0.376, 1.067) 
0.843 (0.507, 1.403) 
 
 
 
0.983 (0.544, 1.777)
 
 
1.043 (0.588, 1.849) 
 
 
 
.050 
.024 
Optimism 
   Avoidance 
   Intrusion 
 
0.935 (0.895, 0.976)
 † 
0.917 (0.876, 0.960)
‡ 
 
0.915 (0.871, 0.961)
‡ 
0.934 (0.889, 0.892)
 †
 
 
0.983 (0.929, 1.040) 
0.952 (0.902, 1.006) 
 
<.001 
.003 
Social Support 
   Avoidance 
   Intrusion 
 
0.999 (0.972, 1.030) 
1.009 (0.979, 1.039) 
 
0.981 (0.951, 1.012) 
0.990 (0.959, 1.022) 
 
0.989 (0.954, 1.024) 
1.001 (0.966, 1.040) 
 
.486 
.615 
Social 
Constraint 
   Avoidance 
   Intrusion 
 
 
1.067 (1.045, 1.089)
 ‡
 
1.062 (1.040, 1.085)
 ‡
 
 
 
1.091 (1.067, 1.116)
 ‡
 
1.088 (1.063, 1.113)
 ‡
 
 
 
1.134 (1.106, 1.163)
 ‡
 
1.107 (1.080, 1.135)
 ‡
 
 
 
<.001 
<.001 
Family history 
of OC in a 
FDR
c 
   Avoidance 
   Intrusion 
 
 
 
2.348 (1.093, 5.043)
 *
 
1.498 (0.676, 3.323) 
 
 
 
1.278 (0.539, 3.026) 
1.137 (0.479, 2.696) 
 
 
 
0.746 (0.274, 2.032) 
0.668 (0.244, 1.829) 
 
 
 
.026 
.356 
Monitoring
c 
   Avoidance 
   Intrusion 
 
1.161 (1.041, 1.295)
 †
 
1.136 (1.016, 1.271) 
 
1.021 (0.890, 1.151) 
1.024 (0.905, 1.159) 
 
1.021 (0.890, 1.171) 
1.056 (0.923, 1.209) 
 
.010 
.103 
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Table 4.3 cont. 
 
Monitoring* family history of OC in a FDR 
   Avoidance 
   Intrusion 
 
 
 
 
<.001 
.026 
Effect of family 
history when 
monitoring is: 
  Low 
   Avoidance 
   Intrusion 
  Medium 
   Avoidance 
   Intrusion 
  High 
   Avoidance 
   Intrusion 
 
 
 
 
1.922 (1.197, 3.087 )
 †
 
1.622 (0.990, 2.655) 
 
1.573 (1.107, 2.236)
* 
1.755 (1.220, 2.523)
 †
 
 
1.423 (0.940, 2.154) 
1.825 (1.193, 2.794)
 †
 
 
 
 
 
1.516 (0.888, 2.588) 
1.492 (0.871, 2.554) 
 
1.799 (1.218, 2.657)
 †
 
1.957 (1.322, 2.896)
 ‡
 
 
1.960 (1.243, 3.088)
 †
 
2.241 (1.423, 3.529)
 ‡
 
 
 
 
 
1.330 (0.713, 2.483) 
1.243 (0.661, 2.336) 
 
2.371 (1.529, 3.674)
 ‡
 
2.312 (1.497, 3.571)
 ‡
 
 
3.165 (1.921, 5.213)
 ‡
 
3.153 (1.938, 5.128)
 ‡
 
 
a
 P value from overall F-test of fixed effect with 3 degrees of freedom 
b 
Corresponds to a 10 unit increase in age 
c 
Cell values cannot be directly interpreted as estimated mean ratios, as coefficients are involved in 
interaction term 
* 
P < .05 
† 
P < .01
 
‡ 
P < .001 
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Table 4.4 Results from multivariate analysis examining factors associated with OC 
personal risk 
Coefficient OC Risk Perception 
Estimated Mean Response (95% CI) P
a 
Baseline 1-Month 4-Month 
Age
b -0.172 (-0.260, -0.034)
 ‡
 -0.160 (-0.258, -0.074)
 ‡
 -0.166 (-0.258, -0.074)
 ‡
 <.001 
Education -0.054 (-0.086, -0.022)
 ‡ 
 -0.059 (-0.090, -0.027)
 ‡
 -0.052 (-0.085, -0.019)
 †
 .002 
Physical 
Functioning 
-0.003 (-0.006, 0.001) -0.002 (-0.005, 0.002) -0.003 (-0.006, 0.005) .327 
Previous # 
routine TVS 
screens 
0.009 (-0.012, 0.030) 0.007 (-0.014, 0.028) 0.010 (-0.011,0.032) .804 
History of 
abnormal 
TVS screen 
0.104 (-0.144, 0.353) 0.153 (-0.097, 0.404) 0.086 (-0.171, 0.343) .691 
Optimism -0.054 (-0.080, -0.028)
 ‡ 
-0.044 (-0.070, -0.018)
 ‡ 
-0.052 (-0.078, -0.026)
 ‡ 
<.001 
Social 
Support 
0.008 (-0.007, 0.024) -0.001 (-0.018, 0.016) -0.004 (-0.021, 0.013) .371 
Social 
Constraint 
0.016 (0.004, 0.028)
* 
0.019 (0.007, 0.0.31)
 † 
0.018 (0.005, 0.031)
 †
 .020 
Family 
history of OC 
in a FDR 
0.577 (0.373, 0.780)
 ‡
 0.507 (0.302, 0.713)
 ‡
 0.387 (0.179, 0.594)
 ‡
 <.001 
Monitoring 0.033 (-0.019, 0.086) 0.049 (-0.004, 0.102) 0.042 (-0.012, 0.095) .319 
a 
 P value from overall F-test of fixed effect with 3 degrees of freedom 
b 
Corresponds to a 10 unit increase in age
 
* 
P < .05 
† 
P < .01
 
‡ 
P < .001 
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Figure 4.1 Graphical representation of participant flow and longitudinal assessment 
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5 Characteristics Associated with the Trajectory of Cancer-Specific Distress 
Following a False Positive Screening Test Result for Ovarian Cancer 
Introduction 
Previous studies have examined the association between receipt of a false positive TVS 
screening test result for OC and OC-specific distress [17]. Additionally, studies have 
identified characteristics – out of a comprehensive set of demographic, clinical, 
dispositional and social environmental characteristics – are associated with increased 
distress over time. However, little is known about the trajectory of OC-specific distress 
experienced by these women when followed over time or what factors influence 
trajectories of distress. 
Characterizing the distinct trajectories of OC-specific distress following receipt of a false 
positive TVS screening test result for OC increases our understanding of responses to a 
potentially health-threatening event and identifies the types of women most likely to 
experience detrimental effects of screening. Because increased levels of cancer-specific 
distress are associated with decreased quality of life, it is important to focus interventions 
following this experience on moderating the negative effects. 
Results from longitudinal studies examining the changes in breast cancer-specific distress 
over time among women experiencing false positive mammography or benign breast 
biopsies indicate that distress declines over time [12, 55]. Similarly in the OC screening 
setting, investigators observed OC-specific distress among women receiving false 
positive TVS screening test results to be elevated in the short term but decline over time, 
although remaining elevated at four months [11].  
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No previous studies have modeled trajectories of OC-specific distress following receipt 
of an abnormal, yet ultimately benign, TVS screening test result for OC; we expect the 
estimated trajectories to identify women experiencing high, medium and low distress 
levels gradually decreasing over time. Further, based on our previous research, we 
hypothesize lower education, fewer previous routine OC screening tests on the program, 
family history of OC in a FDR, lower dispositional optimism and higher social constraint 
to be associated with an increased likelihood in membership in the highest distress 
trajectory. 
Methods 
Sample 
Participants represent a subset of individuals participating in a broader, quasi-
experimental study evaluating affective, cognitive and behavioral outcomes associated 
with receipt of an abnormal, yet ultimately benign, TVS screening test result identified 
during routine screening through the University of Kentucky Ovarian Cancer Screening 
Program (UKOCSP). Ethical approval for this study was obtained from the University of 
Kentucky Institutional Review Board. 
The UKOCSP offers free, annual screening to asymptomatic women at least 50 years of 
age and asymptomatic women 25-50 years of age with at least one first degree relative 
with OC. Women receiving an abnormal TVS screening test result during the course of 
routine, annual screening are typically asked to return within 2-12 weeks for a repeat 
TVS test.  Women who received an abnormal TVS screening test result within the past 12 
weeks, and scheduled to return for additional follow-up were identified from clinic 
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records. Upon arrival at the clinic at the time of their scheduled follow-up appointment, 
these women met with research staff and consented to participate in the study. All 
participants were enrolled in the study from 2004-2009.   
Procedure 
A baseline interview was conducted by project research staff and was completed 
following study enrollment immediately prior to the participant's scheduled repeat TVS 
screening test. Women completed their baseline assessment prior to their scheduled 
repeat TVS screening test. Following, women also completed two follow-up telephone 
interviews, one month and four months after their baseline assessment. All women were 
notified prior to the one month follow-up interview that results of their repeat TVS 
screening test were benign. Less than 5% of eligible women who were invited to 
participate declined participation.  
Measures 
All participants completed questionnaires assessing demographic and clinical 
information, dispositional characteristics, social environmental characteristics, mental 
and physical functioning, risk perception, and distress. Demographic, clinical, 
dispositional and physical functioning information was assessed only at baseline, whereas 
risk perception, social environmental and distress information was captured at baseline 
and both follow-up assessments. Only baseline measures of social environmental 
variables were used in subsequent analyses. 
Demographic and clinical information 
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Demographic information assessed by self-report included age, race/ethnicity, partner 
status, education, income and clinical information relevant to OC risk including personal 
history of breast and colorectal cancer and family history of OC. Family history of OC 
(yes vs. no) was determined based on whether or not the woman had a FDR with OC 
(mother, sister or daughter). Clinical information collected from clinic records included 
number of previous TVS screening tests and history of abnormal TVS screening test 
result (yes versus no). 
Dispositional characteristics 
Dispositional optimism was assessed using the Life Orientation Test-Revised (LOT-R) 
[59]. The LOT-R is a standardized, commonly used 10-item measure of dispositional 
optimism and yields a total optimism score. Informational coping style was measured 
using the Miller Behavioral Styles Scale-Short Form (MBSS-SF) [60]. The MBSS-SF 
consists of 2 stressor scenarios followed by 8 statements representing different coping 
strategies for that stressor. Separate Monitoring and Blunting scores were computed. 
Only the Monitoring score was used in subsequent analyses.  
Social environmental characteristics 
Social support was assessed using the Duke-UNC Functional Social Support 
Questionnaire (Duke-SSQ) [78]. The Duke-SSQ is a standardized, commonly used, 8-
item measure of functional social support yielding a total functional (i.e. affective) social 
support score. Social constraint was assessed using the 15-item "Friends and Family" 
version of  Social Constraint Scale (SCS) [73]. The SCS is a commonly used measure of 
the extent an individual's social environment inhibits expression of thoughts and feelings 
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about a stressful event – in this case, "your experience with ovarian cancer screening". A 
total social constraint score is calculated. 
Physical Functioning 
Physical functioning was assessed using the Medical Outcomes Study 12-Item Short 
Form Health Survey (SF-12) [61]. The SF-12 is a standardized, commonly used 12-item 
measure of physical and mental health status in both medical and healthy examples. The 
physical functioning subscale score was used in subsequent analyses. 
OC-Specific distress 
OC-specific distress was assessed by the Impact of Events Scale (IES) [63]. The IES is a 
standardized, commonly used 15-item measure of current distress associated with a 
specific stressor. Women completed the IES with regard to “the possibility that you will 
develop ovarian cancer in your lifetime." The IES yields subscale scores for Intrusion and 
Avoidance. The Intrusion subscale consists of 7 items which measure intrusive symptoms 
(intrusive thoughts, nightmares, unpleasant feelings and imagery). The Avoidance 
subscale consists of 8 items which measure avoidance symptoms (numbing of 
responsiveness, avoidance of feelings, situations and ideas). Respondents are asked to 
rate the frequency of each item occurring within the past 7 days according to the scale: 
(0) not at all, (1) rarely, (3) sometimes and (5) often. Responses are summed over each 
subscale, with the following possible range of responses: Intrusion (0-35) and Avoidance 
(0-40). A copy of the IES instrument is available in the Appendix. 
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Statistical Analyses 
Two group-based trajectory models [80, 81] were fit to identify the trajectories of 
psychological response - one for each subscale of the IES instrument. Each group-based 
trajectory model assumes that there exist two or more groups having modest within-group 
variation but notable between-group variation. A latent categorical variable - here, 
referred to as class – is introduced to define group membership. At each level of class, a 
typical trajectory is estimated. The estimated relative probability of membership in a 
group is then expressed in terms of the independent variables.  
The underlying distribution is assumed to follow a Zero-Inflated Poisson distribution to 
account for the excess presence of zeros in the response data. The number of groups and 
shape of each trajectory were chosen in such a way to simultaneously optimize the 
Bayesian Information Criterion (BIC) and restriction that an estimated 20% of the 
population be represented in each trajectory. BIC is a commonly used statistic to compare 
goodness of fit between models. BIC is comprised of measures of how well the model fits 
the sample and model complexity. BIC favors more parsimonious models. The final 
model was chosen such that the trajectories were distinct and interpretable.   
After the specification of the appropriate number of groups and trajectory shapes, time-
invariant covariates were added to the model to examine the association of demographic, 
clinical, dispositional and social environmental characteristics on group membership.  
Mean and standard deviations, medians and interquartile ranges, or frequencies of 
covariates across estimated trajectories were reported for both outcomes, as appropriate. 
Estimated ratios of probabilities of group membership from the multivariate model were 
80 
 
presented as estimated odds-like ratios (OLR), with accompanying 95% confidence 
intervals (CI) and p values. All analyses were performed using SAS Version 9.3 (Cary, 
NC) for Windows, with an alpha level of 0.05 throughout. 
Results  
The group-based trajectory analysis included 373 women receiving false positive TVS 
screening test results during routine screening through the UKOCSP. Figures 5.1 and 5.2 
represent the estimated trajectories for Avoidance and Intrusion subscale scores 
respectively, as measured by the IES. Three distinct trajectories of similar shape were 
identified: class 1- no distress, class 2-medium decreasing and class 3- high decreasing 
for both the IES-Avoidance and IES-Intrusion subscales. For the Avoidance model the 
class proportions were 30.0%, 48.2% and 21.8%, respectively (Figure 5.1). For the 
Intrusion model the class proportions were 34.4%, 36.7% and 28.9%, respectively 
(Figure 5.2). 
To identify predictors associated with the probabilities of group membership in various 
trajectories both models were re-estimated with the inclusion of time-invariant covariates. 
Descriptive statistics of covariates by class membership are displayed in Table 5.1. It is 
important to note this table does not take into account uncertainty regarding group 
membership, but mean posterior probabilities of group membership, given covariates 
were very high. For the Avoidance models, estimated probabilities over subjects were 
94%, 96% and 95% for class 1, class 2 and class 3, respectively. For the Intrusion model, 
mean probabilities were 94%, 93% and 94% for class 1, class 2 and class 3, respectively.  
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Results of the covariate-adjusted models are displayed in Table 5.2. Cell values contain 
estimated odds-like ratios and accompanying 95% confidence intervals and p values. For 
continuous covariates, the class 2 versus class 1 OLR represents the factor by which the 
estimated relative probability of group membership in class 2 versus class 1 is multiplied 
for every unit increase in the covariate, controlling for all other factors. For categorical 
covariates, the class 2 versus class 1 OLR represents the ratio of the estimated probability 
of group membership in class 2 to class 1 at the first level of the covariate versus the 
second level of the covariate, controlling for all other factors. 
From Table 5.2 we can see family history of OC in a FDR, no history of an abnormal 
TVS test result and greater social constraint are associated with an increased likelihood of 
membership in class 2 versus class 1 for Avoidance and Intrusion. In other words, women 
with family history of OC in a FDR are more likely to belong to the medium decreasing 
distress trajectory than the no distress trajectory. Similar results are apparent for women 
with no previous history of an abnormal TVS screening test result versus women who 
have gone through the experience of an abnormal test result in the past (estimated 
OLRavd= 2.27, 95% CI= (1.01, 5.00); estimated OLRint= 2.44, 95% CI= (1.04, 5.88); 
Table 5.2).  
Covariates associated with an increased likelihood of membership in the high decreasing 
trajectory versus the no distress trajectory were family history of OC in a FDR, lower 
optimism and increased social constraint, controlling for all other factors. Similar results 
were observed for family history of OC in a FDR as seen in comparing probability of 
class 2 membership to class 1 membership. For both subscale scores of the IES, an 
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increase in dispositional optimism was associated with an increased likelihood of 
membership in the highest decreasing trajectory versus the no distress trajectory.  
Finally, results suggest higher social constraint to be significantly associated with 
increased likelihood of probability in the high decreasing trajectory versus the medium 
decreasing trajectory for both outcomes. For the intrusive model, lower dispositional 
optimism was associated with an increased likelihood of membership in class 3 versus 
class 2 (estimated OLRint= 0.85, 95% CI= (0.77, 0.94); Table 5.2).  
Discussion 
In general, results supported our hypotheses regarding the distinct number of groups and 
trajectory shapes. Estimated trajectories were similar for both models and consistent with 
our expectations. According to results of the group-based trajectory modeling, three 
trajectories adequately characterized women’s responses to false positive TVS screening 
test results. Of clinical importance however, is the identification of women likely 
belonging to the high decreasing trajectory. These women, representing over 20% of the 
sample of women in the study, suffer from the most adverse psychological effects of the 
false positive experience. Among this group, distress decreases from baseline to one-
month, the period when results are confirmed to be benign, but remains elevated even at 
the four-month assessment when compared to women in the other trajectories.  
Although no previous studies have conducted similar trajectory analyses, results from the 
adjusted models are consistent with previous literature evaluating factors associated with 
increased distress in the false positive cancer screening setting.  In the present study, 
lower dispositional optimism, family history of OC in a FDR and high social constraint 
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were associated with a higher likelihood of membership in the high decreasing trajectory 
versus the no distress trajectory for both models, which is consistent with our hypotheses. 
Results from our previous studies suggest lower dispositional optimism, family history of 
OC in a FDR and higher social constraint to be associated with increased OC-specific 
distress. This finding is also consistent with previous research in the breast and ovarian 
cancer setting [17, 55].  
Of most interest are the characteristics distinguishing membership probabilities in class 3 
versus class 2: the high decreasing trajectory versus the medium decreasing trajectory. 
Even after the results of the abnormal test are known to be benign (one-month), distress 
remains elevated at the four-month assessment. For both measures of OC-specific 
distress, high social constraint was consistently associated with an increased likelihood of 
group membership in class 3 versus class 2. This finding may be due to the likely 
membership of women with the highest levels of social constraint in the high decreasing 
(class 3) trajectory, as shown in Figure 5.3. For the Intrusion model, lower dispositional 
optimism was also associated with an increased likelihood in membership in class 3 
versus class 2.  
One may have suspected monitoring informational coping style to be associated with an 
increased likelihood of membership in one of the elevated distress trajectories versus the 
no distress trajectory, as suggested by the Monitoring Process (MP) model[82]. This 
result may be due to the lack of inclusion of the combination of monitoring coping style 
and family history of OC in a FDR in the adjusted models, as suggested by the Cognitive 
Social Health Information Processing (C-SHIP) model [15], as this interaction has been 
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identified with increased OC-specific distress, measured by both subscales of the IES, at 
baseline, one- and four-month assessments [17].   
Contrary to previously conducted studies finding lower education to be associated with 
increased OC-specific distress, we did not observe education to be significantly 
associated with group membership in class 2 or 3 versus class 1, which is likely due to 
the apparent balanced educational level between trajectory members. In Table 5.2, 
without considering the uncertainty associated with group membership, we can see the 
mean number of years of education completed is similar among members of all 
trajectories.  
Strengths and Limitations 
To our knowledge, the present study is the first to use group-based trajectory modeling in 
the context of response to an abnormal, yet ultimately benign, cancer screening test result 
– for any cancer screening test, not just TVS for OC. Also, this study is the largest study 
of response to false positive TVS screening test results over time for OC to date.  
Several limitations to the present study should be noted. OC screening is not currently 
recommended for mass screening of asymptomatic women, and therefore it is unknown 
whether our results can be generalized to other cancer screening tests that are broadly 
recommended (i.e. mammography). Further, our sample was comprised of predominantly 
Caucasian women and thus our findings may not be generalizable to racial/ethnic 
minority women.   
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Conclusions 
Results from this study suggest distinct, interpretable trajectories of OC-specific distress 
not only exist, but follow our expectations with regard to their characterization. Based on 
findings from previous studies and the present study’s results, we can infer that a notable 
proportion of women experiencing false positive screening test results suffer high levels 
of OC-specific distress that only slightly dissipates over a four month period. Further 
research should determine whether results can be extrapolated to other cancer screening 
settings, i.e. mammography, where there exists a higher likelihood of false positive 
results and mass screening of asymptomatic women is recommended. If we can identify 
women at highest risk for suboptimal responses, we can focus interventions to aid in the 
moderation of OC-specific distress following this event.  For the OC screening setting, 
this would include women with low dispositional optimism and a social environment 
characterized by high constraint. 
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Table 5.1 Distribution of demographic, clinical, dispositional and social 
environmental characteristics by estimated trajectory 
 
Avoidance 
Covariates Class 1 
No distress 
N=118 
Class 2 
Medium 
decreasing 
N=181 
Class 3 
High decreasing 
N=74 
Mean (SD), median 
(IQR) or % 
Mean (SD), 
median (IQR) or 
% 
Mean (SD), 
median (IQR) or 
% 
Age 58.3 (11.7) 56.1 (12.2) 55.7 (10.3) 
Years of education 14.2 (2.9) 14.0 (2.7) 13.8 (2.9) 
Number of previous routine TVS tests 2.5 (1.0-8.0) 2.0 (1.0-8.0) 1.5 (0.0-5.0) 
No history of abnormal TVS test result 72.9 82.3 82.4 
Family history of OC in a FDR 22.0 36.5 32.4 
Physical functioning 79.0 (28.0) 78.7 (29.5) 77.0 (27.7) 
Optimism 17.6 (3.4) 16.3 (3.7) 15.1 (3.7) 
Monitoring 3.3 (1.6) 4.0 (1.7) 3.9 (1.8) 
Social support 38.0 (34.0-40.0) 36.0 (31.0-39.0) 33.0 (28.5. 37.0) 
Social constraint 16.0 (15.0-18.0) 19.0 (15.5-25.0) 27.0 (20.5, 34.5) 
 
Intrusion 
Covariates Class 1 
No distress 
N=143 
Class 2 
Medium 
decreasing 
N=140 
Class 3 
High decreasing 
N=90 
Mean (SD), median 
(IQR) or % 
Mean (SD), 
median (IQR) or 
% 
Mean (SD), 
median (IQR) or 
% 
Age 57.7 (11.6) 57.9 (10.8) 53.3 (12.6) 
Years of education 14.5 (2.9) 13.9 (2.7) 13.6 (2.8) 
Number of previous routine TVS tests 2.0 (1.0-8.0) 2.0 (0.0-7.5) 1.0 (0.0-4.0) 
No history of abnormal TVS test result 72.0 83.6 84.4 
Family history of OC in a FDR 22.4 32.9 42.2 
Physical functioning 78.0 (29.4) 80.9 (26.9) 75.6 (30.2) 
Optimism 17.7 (3.3) 16.6 (3.3) 14.3 (4.0) 
Monitoring 3.3 (4.2) 3.7 (1.7) 4.3 (1.9) 
Social support 38.0 (33.0-40.0) 36.0 (30.0-39.0) 36.0 (31.0-39.0) 
Social constraint 16.0 (15.0-19.0) 20.0 (15.0-26.0) 25.5 (19.0-32.0) 
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Table 5.2 Multivariate associations between demographic, clinical, dispositional and social environmental 
characteristics and estimated OC-specific distress trajectories 
 Medium decreasing 
versus no distress 
(Class 2 versus Class 1) 
High decreasing versus no 
distress 
(Class 3 versus Class 1) 
High decreasing versus 
medium decreasing 
(Class 3 versus Class 2) 
Estimated OLR  
(95% CI) 
Estimated OLR 
 (95% CI) 
Estimated OLR  
(95% CI) 
Age
a
 
   Avoidance  
   Intrusion 
 
1.02 (0.75, 1.37) 
1.28 (0.94, 1.76) 
 
1.07 (0.72, 1.59) 
1.05 (0.70, 1.56) 
 
1.05 (0.75, 1.47) 
0.82 (0.56, 1.19) 
Years of education 
   Avoidance  
   Intrusion 
 
0.96 (0.86, 1.06) 
0.91 (0.81, 1.02) 
 
0.94 (0.8, 1.09) 
0.86 (0.74, 0.99) 
 
0.98 (0.87, 1.11) 
0.94 (0.83, 1.07) 
Number of previous routine TVS tests 
   Avoidance  
   Intrusion 
 
1.01 (0.93, 1.07) 
0.99 (0.92, 1.07) 
 
0.97 (0.89, 1.07) 
0.92 (0.83, 1.01) 
 
0.97 (0.90, 1.05) 
0.93 (0.85, 1.02) 
No history of abnormal TVS test result 
   Avoidance  
   Intrusion 
 
2.27 (1.01, 5.00)
* 
2.44 (1.04, 5.88)
* 
 
2.27 (0.76, 6.67) 
2.08 (0.68, 1.46) 
 
1.02 (0.39, 2.63) 
0.86 (0.30, 2.47) 
Family history of OC in a FDR 
   Avoidance  
   Intrusion 
 
2.59 (1.27, 5.25)
** 
3.00 (1.42, 6.33)
 **
 
 
2.86 (1.13, 7.20)
* 
5.01 (2.07, 12.14)
* 
 
1.10 (0.51, 2.36) 
1.66 (0.78, 3.53) 
Physical functioning 
   Avoidance  
   Intrusion 
 
1.01 (0.99, 1.02) 
1.01 (1.01, 1.03)
* 
 
1.01 (0.99, 1.03) 
1.01 (0.99, 1.02) 
 
1.01 (0.99, 1.02) 
0.99 (0.98, 1.02) 
Optimism 
   Avoidance  
   Intrusion 
 
0.95 (0.97, 1.04) 
0.92 (0.83, 1.02) 
 
0.88 (0.78, 0.99)
 * 
0.78 (0.70, 0.88)
 *
 
 
0.93 (0.84, 1.02) 
0.85 (0.77, 0.94)
** 
Monitoring 
   Avoidance  
   Intrusion 
 
1.20 (1.01, 1.44)
* 
1.17 (0.98, 1.40) 
 
1.19 (0.94, 1.50) 
1.36 (1.09, 1.70) 
 
0.99 (0.82, 1.20) 
1.17 (0.96, 1.42) 
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Table 5.2 cont. 
Social support 
   Avoidance  
   Intrusion 
 
0.89 (0.93, 1.04) 
1.02 (0.96, 1.08) 
 
1.01 (0.93, 1.08) 
1.39 (1.03, 1.21) 
 
1.02 (0.96, 1.09) 
1.09 (1.02, 1.17)
* 
Social constraint 
   Avoidance  
   Intrusion 
 
1.17 (1.08, 1.26)
*** 
1.15 (1.08, 1.23)
 ***
 
 
1.29 (1.19, 1.41)
 *** 
1.26 (1.17, 1.36)
 ***
 
 
1.11 (1.06, 1.16)
 *** 
1.10 (1.04, 1.15)
 ***
 
*
p < .05, 
**
 p < .01, 
 ***
p < .001 
a 
Corresponds to a 10-unit increase in age 
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Figure 5.1 Estimated trajectories: IES-Avoidance 
 Figure 5.1 Estimated trajectories of OC-specific distress as measured by the IES Avoidance subscale in 
group-based trajectory modeling (N=373). Class membership based on posterior probabilities from 
unconditional model. The lines represent the fitted means and 95% confidence intervals. 
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Figure 5.2 Estimated trajectories: IES-Intrusion 
Figure 5.2. Estimated trajectories of OC-specific distress as measured by the IES Intrusion subscale in 
group-based trajectory modeling (N=373). Class membership based on posterior probabilities from 
unconditional model. The lines represent the fitted means and 95% confidence intervals. 
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Figure 5.3 Distribution of social constraint by estimated trajectory membership 
Figure 5.3. Group membership determined by subject’s highest estimated group membership probability 
from group-based trajectory modeling (N=373).  
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6 Discussions and Conclusions 
Summary 
This chapter provides a summary of the previous five chapters as well as discusses the 
individual and public health implications of our research findings, strengths and 
limitations of this research and recommendations for future research. Four papers were 
presented in this dissertation: (1) Consequences of False Positive Cancer Screening Test 
Results for Ovarian Cancer: A Literature Review; 2) Affective, Cognitive and Behavioral 
Outcomes Associated with A False Positive Screening Test for Ovarian Cancer; 3) 
Demographic, Clinical, Dispositional and Social Environmental Characteristics 
Associated with Cancer-Specific Distress and Perceived Risk Following Receipt of A 
False Positive Screening Test Result for Ovarian Cancer: A Longitudinal Study; and 4) 
Characteristics Associated with the Trajectory of Cancer-Specific Distress Following a 
False Positive Screening Test Result for Ovarian Cancer. 
The first paper (Chapter Two) was a comprehensive literature review that focused on 
responses to false positive cancer screening test results and what factors may moderate 
the magnitude and trajectory of potential responses. The purpose of this chapter was to 
evaluate relevant existing literature pertaining to response to a potentially health-
threatening event and provide guidance into what factors may explain how one reacts to 
such an event. The review included studies focused on the breast and ovarian cancer 
screening settings and examined both negative and positive outcomes experienced 
following the event.  
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In general, results from this review suggested that women receiving false positive cancer 
screening test results experience increased cancer-specific distress which is most apparent 
immediately following receipt of the test result and dissipates over time but may still 
remain elevated relative to baseline. Although a multitude of literature evaluates the 
adverse affective outcomes associated with false positive screening test results, little 
research has included measures of positive affective outcomes such as benefit-finding 
and perceived positive psychological consequences of screening.  For cognitive 
outcomes, a few studies have been conducted to evaluate the association between false 
positive cancer screening test results and perceptions of lifetime personal (absolute) risk 
and comparative risk. While results suggest perceptions of lifetime risk to be increased 
among women in the false positive group compared to the routine screening group, 
sample sizes in each group were fairly small. For general beliefs regarding the efficacy of 
cancer screening on reducing overall cancer mortality, no studies have directly addressed 
this question in the context of ovarian cancer screening. From the breast cancer screening 
literature, results are contradictory. Although literature exists examining the potential 
behavioral effects of false positive cancer screening test results, most studies focus on the 
cervical and breast cancer screening setting and results are inconsistent. 
Also discussed in the first paper were two theoretical models that provide insight into 
what factors may moderate women’s response to potentially health-threatening events – 
here, receipt of a false positive TVS screening test result. Throughout Chapter Two, the 
MP and C-SHIP models showed that a person’s informational coping style, situational 
and dispositional characteristics explain how individuals process and react to threatening 
information. Additionally, a few studies have examined factors associated with the 
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magnitude and trajectory of cancer-specific distress over time. However, these studies 
involved a limited sample of women who have actually received false positive cancer 
screening test results and the focused on fewer outcomes.       
The second paper, Chapter Three, provides the largest, most comprehensive study to date 
focusing on the impact of false positive cancer screening test results on psychological and 
behavioral outcomes. The study included 750 women: 375 in the abnormal screening 
(AS) group and 375 in the routine screening (RS) group. Results from this longitudinal 
study suggested receipt of a false positive TVS test result impacted a variety of affective, 
cognitive and behavioral outcomes. Additionally, results suggested women in the AS 
group experience increased OC-specific distress, less perceived positive consequences of 
screening and increased perceptions of lifetime OC risk compared to women receiving 
normal, routine screening results. The majority of our hypotheses were supported and 
most findings were consistent with the literature. However, this study is the first to 
examine the effect of a false positive cancer screening test result on positive affective 
outcomes and beliefs about the efficacy of screening. Although our study lacked 
significant findings regarding hypotheses in the domains, study results offer guidance to 
future researchers to better characterize attitudes and beliefs regarding screening efficacy. 
Further, this study provided the largest evaluation of behavioral outcomes in the false 
positive cancer screening context. Results indicated women’s intentions to participate in 
future ovarian, breast and colorectal cancer screenings were not affected by a false 
positive screening test for OC. However, results regarding intention to participate in 
future screening may have been limited due to lack of variability in the single ordinal 
measure question which was used in the questionnaire. 
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Chapter Four included only women in the AS study group, and focused on identifying 
demographic, clinical, dispositional and social environmental characteristics associated 
with the magnitude of OC-specific distress over time. Although some studies have 
addressed factors associated with increased cancer-specific distress in this context, 
perceptions of personal cancer risk have not formerly been addressed. Additionally, this 
study evaluated the association between outcomes and a comprehensive set of factors at 
all assessment points, whereas previous studies have examined outcomes only cross-
sectionally. Using a generalized linear shared random-effects mixed model, this study 
simultaneously addressed both subscales of the IES - Avoidance and Intrusion, while 
controlling for their assumed correlation. In general, results were consistent with the 
literature and extended characterization of outcomes to include follow-up assessments. 
The main findings regarding OC-specific distress suggested less education, more 
previous routine TVS screens on the program, no history of an abnormal test result, less 
optimism and more social constraint to be associated with greater OC-specific distress. 
Additionally, the combination of a monitoring informational coping style with family 
history of OC in a FDR was association with increased distress at all assessments, as 
suggested by the C-SHIP model and previous researchers. For perceptions of personal 
OC risk, lower age, less education, family history of OC, less optimism and increased 
social constraint were associated with greater perceived risk at all assessments.   
The last paper, Chapter Five, modeled trajectories of OC-specific distress response over 
the four-month study period as well as identified characteristics associated with an 
increased likelihood of membership in one trajectory versus another. Using group-based 
trajectory modeling, three distinct classes of trajectories of response were estimated. In 
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each of the models, the majority of the sample was estimated to belong to the medium 
decreasing (class 2) group. These women experience immediate increased OC-specific 
distress when notified their test results are abnormal and require additional follow-up. 
However, after the results of the additional follow-up TVS test are known to be benign, 
distress decreases and tends to remain constant up to four-months following. Of most 
interest in this study, is the identification of characteristics of women more likely to 
belong to the highest distress estimated trajectory.  Although increased social constraint 
was the only characteristic distinguishing in likelihood of membership in the highest 
decreasing trajectory and the medium decreasing trajectory (class 3 versus class 2), there 
were many characteristics associated with increased likelihood of membership in the 
highest estimated trajectory and lowest (no distress) trajectory. Here, family history of 
OC in a FDR, lower dispositional optimism and increased social constraint were 
associated with an increased likelihood of group membership. Although no previous 
studies have modeled trajectories of response, results were consistent with our 
expectations based on results from the previously conducted studies in this dissertation.  
All studies conducted in this dissertation involve participants from the same study and 
answer similar questions regarding the psychological and behavioral impact of a false 
positive TVS screening test result. Together, results provide a comprehensive evaluation 
of the impact of a false positive screening test result for OC – from evaluating what 
endpoints are affected to specifically characterizing the types of women most likely to be 
at high risk for experiencing adverse psychological and cognitive outcomes. 
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Implications 
Results from these studies have implications for women considering participation in 
cancer screening programs, as well as public health efforts aimed to identify efficacious 
screening methods to reduce OC mortality and the development of interventional 
programs to moderate distress following a false positive test result. All previous chapters 
of this dissertation provide support that women experiencing false positive test results 
during participation in routine, annual screening programs of asymptomatic individuals 
are likely to suffer increased cancer-specific distress and perceptions of absolute and 
comparative cancer risk.  
 From a public health perspective, it is important to understand whether or not receipt of a 
false positive cancer screening test result for OC is associated with reduced beliefs about 
the efficacy of screening or intentions to participate in other screening modalities which 
are recommended for mass screening, such as mammography by professional 
organizations. From this dissertation, we can conclude that attitudes and beliefs and the 
efficacy of OC, breast cancer and colorectal cancer modalities do not appear to be 
affected by the false positive experience. In fact, results indicated that women in our 
study believed that cancer screening is highly effective. However, it remains unclear if 
behavior to participate in these programs is affected. 
While our studies identify an increase in negative psychological response, the overall 
trend seems to dissipate by four-months but remain elevated relative to baseline levels, 
suggesting the impact is experienced in the immediate and short-term. However, from a 
public health perspective, it should be noted that over 20% of the women in the abnormal 
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screening group were estimated to belong to class 3, high decreasing, in the trajectory 
modeling (Chapter Five). Although distress among these women also decreases over 
time, it remains elevated even at four-months, compared to the other two trajectories. 
Because a notable proportion of TVS screening tests are likely to be false positives, these 
potential effects should be considered to identify women likely to suffer the most adverse 
responses and intervene to moderate distress levels.  
Strengths and Limitations 
The compilation of these studies provides the most comprehensive examination of 
response to a false positive cancer screening test result in the OC setting. Not only in 
regard to the plethora of outcomes examined, but also the in-depth examination of the 
false positive study group over time. Our studies include the largest sample sizes, 
longitudinal assessment of study outcomes and advanced statistical techniques to more 
appropriately address associations of interest. No previous studies have modeled 
trajectories of response in the abnormal cancer screening setting. As a whole, this 
dissertation provides insight into all aspects of response to the abnormal cancer screening 
experience.    
Several limitations to our research should be noted. First, because screening for OC is not 
recommended by any professional organization, it is unknown whether our results are 
generalizable to other populations for which mass screening is recommended. Second, 
the overwhelming majority of women participating in this study were Caucasian and at 
least high school educated. Additionally, individuals in this study were participants in a 
free cancer screening program. Therefore, our study may lack external validity, as our 
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results may not be generalizable to ethnic/minority, less than high school educated 
women or those willing to participate in a fee-for-service screening program.  
Future Research 
Findings from this dissertation point to various potential avenues for future research 
opportunities. Throughout this dissertation we have identified characteristics associated 
with women at the highest risk for experiencing adverse psychological issues following 
receipt of an abnormal, but benign, TVS screening test result for OC. The first direction 
future research should focus on is development of an interventional program designed to 
moderate adverse effects experienced by these women.  The second direction should 
focus on adequately measuring the impact of false positive screening on actual future 
participation in cancer screening programs.  
Although an extensive review of the literature examining psycho-educational intervention 
programs for cancer screening is necessary before providing specific recommendations 
on what kind of program should be developed to moderate responses following abnormal 
screening test results, we can identify women at highest need for participation in such a 
program. Findings from this dissertation suggest the intervention be implemented during 
the 4-8 week period of uncertainty between the initial receipt of an abnormal TVS 
screening test result and follow-up TVS testing when the highest levels of OC-specific 
distress are experienced. However, because these women belonging to the high 
decreasing estimated trajectory (Chapter Five) still have high distress levels at four-
months, it would be necessary to evaluate the use of an intervention over the entire 
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period.  The specification of the form of the intervention (clinic-based, telephone-based, 
etc.) should be determined based on a more extensive literature review.  
Because it is unknown whether increased risk perceptions are likely to motivate or hinder 
participation in risk-reducing behaviors, such as participation in cancer screening 
programs, future research should be conducted in this context. Further, research is needed 
to characterize the impact of a false positive cancer screening test result on actual 
behavior, i.e. returning for recommended screening. Impacts on screening behavior 
should be evaluated not only for the same screening modality for which the false positive 
screening test was received, but also cancer screening participation for which an 
individual is recommended.  
Responses to false positive cancer screening test results and their potential harm to 
individuals should remain a concern for clinicians, public health officials and researchers 
when considering the potential negative impact of mass screening programs.
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Appendix 
 
IMPACT OF EVENT SCALE (IES) 
DIRECTIONS: Below is a list of comments made by people after stressful life events. 
Please check each item, indicating how frequently the comments were true for you 
DURING THE PAST SEVEN DAYS regarding the possibility of you developing 
OVARIAN CANCER someday. If they did not occur, please mark the “Not at all” column. 
  Not at 
all 
Rarely Sometimes Often 
1. I thought about it when I didn’t mean to. 
 
     
2. I avoided letting myself get upset when I  
    thought about it or was reminded of it. 
 
     
3. I tried to remove it from memory.      
 
4. I had trouble falling asleep or staying  
    asleep, because of pictures or thoughts  
    about it that came into my mind. 
     
 
5. I had waves of strong feelings about it. 
     
 
6. I had dreams about it. 
     
 
7. I stayed away from reminders of it. 
     
 
8. I felt as if it hadn’t happened or it  
    wasn’t real. 
     
 
9. I tried not to talk about it. 
     
 
10. Pictures about it popped into my mind. 
     
 
11. Other things kept making me think     
       about it. 
     
 
12. I was aware that I still had a lot of  
      feelings about it, but I didn’t deal with     
      them. 
     
 
13. I tried not to think about it. 
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14. Any reminder brought back feelings about    
       it. 
     
 
15. My feelings about it were kind of numb. 
     
  0 1 3 5 
Intrusion subset= 1, 4, 5, 6, 10, 11, 14; Avoidance subset= 2, 3, 7, 8, 9, 12, 13, 15. 
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